captopril has been researched along with Cardiovascular Stroke in 492 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (9.35) | 18.7374 |
| 1990's | 255 (51.83) | 18.2507 |
| 2000's | 155 (31.50) | 29.6817 |
| 2010's | 33 (6.71) | 24.3611 |
| 2020's | 3 (0.61) | 2.80 |
| Authors | Studies |
|---|---|
| Kravchun, PG; Martovytskyi, DV; Shelest, OM | 1 |
| Christie, RM; Hansen, HH; Hecksher-Sørensen, J; Jelsing, J; MacKrell, JG; Pedersen, PJ; Rolin, B; Roostalu, U; Salinas, CG; Skytte, JL; Thisted, L; Vrang, N; Zois, NE | 1 |
| Djerada, Z | 1 |
| Krzemiński, TF; Mitręga, KA; Nożyński, J; Porc, M; Spałek, AM; Stankiewicz, M | 1 |
| Fan, Y; Mann, MJ; Simpson, PC; Xu, Y; Yang, YL; Yeh, CC | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 4 |
| Chen, SA; Chen, YR; Chou, YH; Fu, YC; Kuo, TBJ; Lai, CT; Lin, WL; Liu, SH; Lo, LW; Yamada, S; Yang, CCH | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD; Omboni, S; Reggiardo, G | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D; Omboni, S; Reggiardo, G | 3 |
| Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
| Borghi, C; Del Corso, F; Pareo, I | 1 |
| Califf, RM; Kober, L; Lewis, EF; Li, Y; Pfeffer, MA; Reed, SD; Rouleau, JL; Schulman, KA; Solomon, SD; Velazquez, EJ; Weinfurt, KP; White, HD | 1 |
| Andersson, P; Bratt, J; Cederholm, T; Heimbürger, M; Palmblad, J | 1 |
| Ferrario, CM; Flores-Monroy, J; Hernández-Campos, ME; Martínez-Aguilar, L; Valencia-Hernández, I | 1 |
| Ambrosioni, E; Borghi, C; Campesi, I; Franconi, F; Omboni, S; Reggiardo, G | 1 |
| Califf, R; Claggett, B; Køber, L; Lam, CS; Lewis, E; Liu, J; McEntegart, M; McMurray, JJ; Pfeffer, M; Rouleau, J; Skali, H; Solomon, S; Velazquez, E | 1 |
| Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R | 1 |
| Ali, MJ; Bradley, JM; Cirino, G; Donnarumma, E; Evangelista, S; Goodchild, TT; Islam, KN; Jenkins, JS; Lefer, DJ; Organ, CL; Patel, RA; Polhemus, DJ; Rushing, AM; Scarborough, AL | 1 |
| Cheng, WJ; Hu, HS; Wang, LX; Xing, QC; Xue, M; Yan, SH | 1 |
| Ambrosioni, E; Borghi, C; Cicero, AF | 1 |
| Anker, SD; Belonje, AM; Dickstein, K; Ponikowski, P; van Veldhuisen, DJ; von Haehling, S; Voors, AA; Westenbrink, BD | 1 |
| Araujo, IG; Costa-E-Sousa, RH; Mecawi, AS; Olivares, EL; Reis, LC; Sonoda-Côrtes, R; Trindade, DC; Werneck-de-Castro, JP | 1 |
| Blankesteijn, WM; Daemen, MJ; Fujimoto, A; Fujimoto, S; Hofstra, L; Isobe, S; Li, P; Lovhaug, D; Narula, J; Narula, N; Petrov, A; Pitt, B; Reutelingsperger, C; Smits, JF; van den Borne, SW; Vannan, MA; Wong, ND; Zandbergen, HR; Zannad, F | 1 |
| Ararat, E; Brozovich, FV | 1 |
| Castellano, L; Do, R; Gaballa, M; Goldman, S; Hagerty, T; Juneman, E; Kellar, R; Lancaster, J; Schmelz, M; Sethi, G; Thai, HM; Williams, S | 1 |
| Califf, RM; Diaz, R; Leimberger, JD; Lewis, EF; Lokhnygina, Y; McMurray, JJ; Murin, J; Pfeffer, MA; Velazquez, EJ | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD | 1 |
| Farhang, S; Javadzadegan, H; Mehdizadeh Baghbani, J | 1 |
| Campos, RR; Carillo, BA; Couto, GK; Prezoto, BC; Rossoni, LV; Schoorlemmer, GH | 1 |
| Asdaq, SM; Inamdar, MN | 1 |
| Al-Khatib, SM; Califf, RM; McMurray, JJ; Pfeffer, MA; Piccini, JP; Pieper, K; Solomon, SD; Van de Werf, F; Velazquez, EJ; Zhang, M | 1 |
| Chen, BJ; Feng, JX; Gao, YL; Li, ZS; Meng, LQ; Su, XX; Xia, XL | 1 |
| Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, J; Signorovitch, JE; Solomon, SD; Swedberg, K; Thune, JJ; Velazquez, E | 1 |
| Chai, LM; Lou, LX; Lü, XY; Wang, SR; Wu, AM; Zhai, JY; Zhang, DM | 1 |
| Abuladze, GV; Erkomaishvili, IG; Narsiia, EV; Nebieridze, MI; Pipiia, NG | 1 |
| Acet, A; Ozer, MK; Parlakpinar, H | 1 |
| Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM | 1 |
| Amigoni, M; Califf, R; Køber, L; Levine, RA; McMurray, JJ; Meris, A; Pfeffer, MA; Solomon, SD; Thune, JJ; Velazquez, E; Verma, A | 1 |
| Ebina, T; Hibi, K; Kimura, K; Kosuge, M; Kusama, I; Morita, S; Nozawa, N; Okuda, J; Ozaki, H; Tsukahara, K; Umemura, S; Yano, H | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
| Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Carubelli, V; Castrini, AI; Dei Cas, L; Inama, L; Lazzarini, V; Lombardi, C; Metra, M | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Spooner, PH | 1 |
| Bicket, DP | 1 |
| Dickstein, K; Kjekshus, J | 3 |
| Sato, H | 1 |
| Gayet, JL | 1 |
| Achard, JM; Andrejak, M; Fournier, A; Godefroy, O; Slama, M | 1 |
| Martínez-Sellés, M | 1 |
| Chowdhary, S; Townend, JN | 1 |
| Filippi-Codaccioni, E; Hamon, M | 1 |
| Ambrosioni, E; Borghi, C | 2 |
| Chida, M; Fujii, R; Fukuchi, M; Ido, T; Imahori, Y; Kagaya, Y; Namiuchi, S; Otani, H; Shirato, K; Takeda, M; Tezuka, F; Watanabe, J; Yamane, Y | 1 |
| Danchin, N | 1 |
| Doggrell, SA | 1 |
| de Graeff, PA; de Zeeuw, D; Grobbee, DE; Hillege, HL; Navis, G; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ | 1 |
| Alam, SE; Arnaout, MS; Khalil, A | 1 |
| Braunwald, E; Goldman, S; Lee, D; Pfeffer, MA; Plappert, T; Rouleau, JL; St John Sutton, M | 1 |
| Bach, LA; Burrell, LM; Dean, RG | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD | 1 |
| Dickstein, K | 1 |
| Baggi, JM; Brandi, JM; Cordeiro, JA; de Godoy, MF; Joaquim, MR; Maia, LN; Nicolau, JC; Santos, M; Vítola, JV | 1 |
| Clarke, K; Cole, MA; Hulbert, K; Lygate, CA; Monfared, M; Neubauer, S | 1 |
| Böger, GI; Böger, RH; Budinger, M; Busse, R; Hoopmann, M; Welte, T | 1 |
| Lapointe, N; Pourdjabbar, A; Rouleau, JL | 1 |
| Califf, RM; Edwards, S; Gallo, P; Henis, M; Kober, L; Leimberger, JD; Maggioni, AP; McMurray, JV; Pfeffer, MA; Rouleau, JL; Sellers, MA; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
| Deswal, A; Mann, DL | 1 |
| Califf, RM; Edwards, S; Henis, M; Køber, L; Leimberger, JD; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Sellers, MA; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, H; Zelenkofske, S | 1 |
| Gensini, GF; Modesti, PA; Vanni, S | 1 |
| Saxena, PR; Schoemaker, RG; Van Kerckhoven, R; van Veghel, R | 1 |
| Pfeffer, M | 1 |
| Alberti, A; Corrada, E; Ferrari, S; Mafrici, A; Marenna, B | 1 |
| McAnulty, JH | 1 |
| Kupfer, Y; Moshenyat, R; Tessler, S | 1 |
| Jorde, UP | 1 |
| Andersen, GS; Dahlström, U; Egstrup, K; Gøtzsche, O; Lahiri, A; Møller, JE; Skagen, K | 1 |
| Liebson, PR | 1 |
| Eriksson, AL; Hedner, T; Hultén, LM; Niklason, A; Ohlsson, C; Skrtic, S; Wiklund, O | 1 |
| Kvan, E; Reikvam, A | 1 |
| Piña, IL | 1 |
| Keltai, M | 1 |
| Buikema, H; de Zeeuw, D; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Baxter, GF; Ebrahim, Z; Yellon, DM | 1 |
| Geltman, EM; Kenchaiah, S; Lamas, GA; Parker, JO; Pfeffer, MA; Plappert, T; Rouleau, JL; Sasson, Z; Solomon, SD; St John Sutton, M | 1 |
| Hasenfuss, G | 1 |
| Solignac, M | 1 |
| Bernstein, V; Braunwald, E; Brown, EJ; Dagenais, GR; Davis, BR; Gordon, D; Kenchaiah, S; Lamas, GA; Pfeffer, MA; Rouleau, JL; Steingart, RM; Sussex, B | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 2 |
| Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ | 1 |
| Anavekar, NS; Califf, RM; Dickstein, K; Kober, L; Leimberger, JD; Maggioni, A; McMurray, JJ; Nordlander, R; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, EJ; White, HD; Zelenkofske, S | 1 |
| Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
| Nguyen, A; Sharma, S | 1 |
| Braunwald, E; Flaker, GC; Goldman, S; Hennekens, CH; Jiménez-Navarro, M; Lamas, GA; Murcia, AM; Pfeffer, MA; Rouleau, JL; Skali, H | 1 |
| Braunwald, E; Chertow, GM; Kenchaiah, S; Moyé, LA; Packer, M; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Tokmakova, MP | 1 |
| Dickstein, K; Lehto, M; Nieminen, MS; Snapinn, S; Swedberg, K | 1 |
| Aukrust, P; Damås, JK; Dickstein, K; Frøland, SS; Gullestad, L; Kjekshus, J; Otterdal, K; Ueland, T; Yndestad, A | 1 |
| Fabbri, G; Maggioni, AP | 1 |
| Feng, YG; Hu, JG; Hu, MS; Wang, H; Yang, JF; Zhou, XM | 1 |
| Balding, LC; Burns, WC; Burrell, LM; Candido, R; Cao, Z; Dean, RG; Twigg, SM | 1 |
| Anavekar, NS; Arnold, JM; Barvik, S; Bourgoun, M; Califf, RM; Ghali, JK; Khrakovskaya, M; McMurray, JV; Pfeffer, MA; Schwartz, Y; Skali, H; Solomon, SD; Velazquez, EJ; Warnica, JW | 1 |
| Arutiunov, GP; Belenkov, IuN; Glezer, MG; Matrynov, AI; Moiseev, VS; Pozdniakov, IuM; Storozhakov, GI; Striuk, RI; Tereshchenko, SN; Zadionchenko, VM | 1 |
| Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Allsbrook, JS; Califf, RM; Masselink, LE; McMurray, JJ; Pfeffer, MA; Radeva, JI; Reed, SD; Schulman, KA; Sellers, MA; Velazquez, EJ; Weinfurt, KP | 1 |
| Aylward, PE; Barvik, S; Califf, RM; Dalby, AJ; Huang, Z; Marin-Neto, JA; McMurray, JJ; Murin, J; Nordlander, RO; Pfeffer, MA; van Gilst, WH; Weaver, WD; White, HD; Zannad, F | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Vasiuk, IuA | 1 |
| Aukrust, P; Dickstein, K; Frøland, SS; Gullestad, L; Kjekshus, J; Omland, T; Squire, IB; Ueland, T | 1 |
| de Resende, MM; Kauser, K; Mill, JG | 1 |
| Borghi, C; Cosentino, E; De Sanctis, D | 1 |
| Califf, R; Howlett, J; Køber, L; Maggioni, A; McMurray, J; Pfeffer, M; Pieper, K; Reed, S; Rouleau, J; Solomon, S; Swedberg, K; Van de Werf, F; Velazquez, E; White, H | 1 |
| Califf, RM; Diaz, R; Ertl, G; Køber, L; Leimberger, JD; Maggioni, AP; Mareev, V; McMurray, JJ; Opolski, G; Pfeffer, MA; Rouleau, JL; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; Zannad, F; Zelenkofske, S | 1 |
| Baltogiannis, GG; Hatzistergos, KE; Kolettis, TM; Kyriakides, ZS; Malamou-Mitsi, V; Mitsi, AC; Niokou, D; Papalois, A; Pappa, L; Tsalikakis, DG | 1 |
| Batyraliev, TA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Califf, RM; Diaz, R; Kober, L; Maggioni, AP; Mareev, V; McMurray, JJ; Murin, J; Reed, SD; Schulman, KA; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
| Buikema, H | 1 |
| Aylward, PG; Califf, RM; Kober, L; McMurray, JJ; Pfeffer, MA; Pieper, KS; Skali, H; Solomon, SD; Stephenson, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
| Ott, P | 1 |
| Chen, JL; Gao, RL; Pei, WD; Sun, YH; Yang, YJ; Zhang, YH; Zhao, JL | 1 |
| Teyssedou, A | 1 |
| Costa-e-Sousa, RH; Marassi, MP; Marinho, A; Martins, OP; Mattos, EC; Olivares, EL; Reis, LC; Trindade, DC; Trindade, RC | 1 |
| Califf, RM; Howlett, J; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Signorovitch, J; Solomon, SD; Thune, JJ; Velazquez, EJ; Zelenkofske, S | 1 |
| Adamson, C; Bahl, JJ; Goldman, S; Greer, K; Hoying, J; Klewer, S; Maitra, N; Morkin, E | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K | 1 |
| Anand, I; Dickstein, K; Manhenke, C; Ng, L; Orn, S; Squire, IB | 1 |
| Al-Khatib, SM; Califf, RM; Kober, L; Lokhnygina, Y; McMurray, JJ; Solomon, SD; Thomas, KL; Velazquez, EJ | 1 |
| Anavekar, NS; Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, E; White, H | 1 |
| Brozovich, FV; Chen, FC | 1 |
| Havranek, EP | 1 |
| Califf, RM; Francis, GS; Huang, Z; Lewis, EF; McMurray, JJ; Pfeffer, MA; Prisant, LM; Thomas, KL; Velazquez, EJ; Weaver, WD | 1 |
| Riecker, G | 1 |
| Cody, RJ | 1 |
| Alexander, RW; Braunwald, E; Ertl, G; Kloner, RA | 1 |
| Boomsma, F; Hugenholtz, PG; Laird-Meeter, K; Man in't veld, AJ; Schalekamp, MA; Simoons, ML; Wenting, GJ; Woittiez, AJ | 1 |
| Chatterjee, K; Parmley, WW | 1 |
| Aranda, JM; Cintrón, G; Hernández-López, E; Linares, E; Ramírez, EA; Rivera del Río, JR | 1 |
| Rømer, FK | 1 |
| Abinader, EG; Malouf, S; Rosenfeld, T; Sharif, D | 1 |
| Ichibangase, A; Ichibangase, J; Inada, M; Iwasaka, T; Onoyama, H; Sugiura, T; Tsuji, H | 1 |
| Bounhoure, JP; Breton, J; Fauvel, JM; Kayanakis, JG; Maillet, J | 1 |
| Hakki, AH; Iskandrian, AS; Manno, BV | 1 |
| Bounhoure, JP; Fauvel, JM; Kayanakis, JG; Puel, J | 1 |
| Brivet, F; Delfraissy, JF; Dormont, J; Giudicelli, JF; Legrand, A; Richer, C | 1 |
| Alexander, JC; Burke, JF; Ferguson, RK; Koplin, JR; Shirinian, A; Vlasses, PH | 1 |
| Braunwald, E; Darsee, JR; DeBoer, LW; Ertl, G; Glogar, DH; Ingwall, JS; Kloner, RA | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Basta, L; Davis, B; Flaker, G; Goldman, S; Hamm, P; Hartley, LH; Lamas, G; Menapace, F; Moye, L; Wun, CC | 1 |
| Kyriakidis, MK; Marakas, SA; Petropoulakis, PN; Toutouzas, PK; Vourlioti, AN | 1 |
| Anversa, P; Capasso, JM; Herman, MV; Li, P; Meggs, LG | 1 |
| Buikema, H; de Graeff, PA; Hegeman, H; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Francis, GS; Rector, TS | 1 |
| Duke, D; Goldman, L; Kuntz, KM; Lamas, GA; Lee, TH; Pfeffer, MA; Soukup, JR; Tsevat, J | 1 |
| Anthonio, RL; Brodde, OE; de Graeff, PA; Hegeman, H; Lie, KI; Scholtens, E; Schulze, C; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Bussmann, WD; Hildenbrand, R; Klepzig, H; Micke, G | 3 |
| Crozier, IG; Foy, SG; Frampton, CM; Ikram, H; Nicholls, MG; Richards, AM; Turner, JG | 2 |
| Franzosi, M; Latini, R; Maggioni, AP; Tognoni, G; Zuanetti, G | 1 |
| Gurbel, PA; O'Connor, CM | 1 |
| Flaker, GC; Gersh, BJ; Lamas, GA; Mitchell, G; Moyé, L; Pfeffer, MA; Rouleau, JL; Rutherford, JD; Smith, SC; Wun, CC | 1 |
| Bucca, V; Caracausi, R; Di Pasquale, P; Licata, G; Parrinello, G; Paterna, S; Pipitone, F | 1 |
| Appleby, P; Boon, N; Collins, R; Flather, M; Foster, C; Hargreaves, A; Kolettis, T; Pipilis, A; Sleight, P | 1 |
| Bonte, J; Le Pen, C; Lévy, E | 1 |
| Bucca, V; Di Pasquale, P; Licata, G; Paterna, S | 1 |
| Cleland, JG | 1 |
| Cerimele, B; Greene, P; Reed, S; Ryan, T; Schwertschlag, U; Voelker, J; Weinberger, M | 1 |
| Kingma, JH; Pinto, YM; Schunkert, H; van Gilst, WH | 1 |
| Jugdutt, BI | 1 |
| Mikus, G; Mörike, K | 1 |
| Chaudhry, GM; Haneef, N | 1 |
| Soyeur, D | 1 |
| Fernandes, JS | 1 |
| de Teresa, E | 1 |
| Bucca, V; Di Pasquale, P; Magatti, M; Maringhini, G; Paterna, S | 1 |
| Sleight, P | 1 |
| Pfeffer, MA | 3 |
| Ambrosioni, E; Bacchelli, S; Borghi, C | 1 |
| Dambrink, JH; Kingma, JH; Lie, KI; Peels, KH; Tuininga, YS; van Gilst, WH | 1 |
| Han, YL; Jing, QM; Tong, M | 1 |
| Connors, KF; Lamas, GA | 1 |
| Blinston, GE; Jugdutt, BI; Jugdutt, SJ; Khan, MI | 1 |
| Montgomery, HE; Speechly-Dick, ME | 1 |
| Basta, L; Braunvald, Iu; Dévis, BR; Fleĭker, GS; Geltman, EM; Goldman, S; Kaddi, TE; Moĭe, LA; Pfeffer, MA | 1 |
| Arnold, JM; Bichet, D; de Champlain, J; Klein, M; Moyé, L; Packer, M; Rouleau, JL; Rouleau, JR; Sestier, F; Sussex, B | 1 |
| Davis, BR; Flaker, GC; Kowey, PR; Lamas, GA; Miller, HS; Moyé, LA; Packer, M; Pfeffer, MA; Rouleau, JL; Rutherford, JD | 1 |
| Dambrink, JH; Kingma, JH; Peels, CH; van Gilst, WH; Verheugt, FW; Wielenga, RP | 1 |
| Preobrazhenskiĭ, DV | 2 |
| Davies, MK | 1 |
| Carlyle, PF; Cohn, JN; Francis, GS; McDonald, KM; Rector, T | 1 |
| Ambrosioni, E; Borghi, C; Magnani, B | 4 |
| Fenwick, MK; Motwani, JG; Struthers, AD | 2 |
| Alberti, KG; Flapan, AD; Fox, KA; Ludlam, CA; Wright, RA | 1 |
| Gøtzsche, CO; Nørgaard, A; Ravkilde, J; Søgaard, P; Thygesen, K | 2 |
| Bralet, J; Gros, C; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC | 1 |
| Cochrane, BS; Follick, MJ; Geltman, E; Gorkin, L; Hamm, P; Jacobson, K; Jacobson, MJ; Sollano, J; Sussex, B; Sylvia, S | 1 |
| Battler, A; Hasdai, D; Leor, J; Ovadia, Z; Varda-Bloom, N | 1 |
| Lüderitz, B | 1 |
| Budaj, A; Cedro, K; Collins, R; Fitzgerald, L; Flather, M; Hargreaves, A; Jacob, A; Kolettis, T; Millane, T; Pipilis, A | 1 |
| Arnold, JM; Davis, BR; Dinh, H; Farnham, DJ; Geltman, E; Hayes, D; Moyé, LA; Pfeffer, MA; Randall, OS; Wun, CC | 1 |
| Kennedy, N; McAlpine, H; Motwani, JG; Struthers, AD | 1 |
| Arnold, JM; Bernstein, V; Cuddy, TE; Dagenais, GR; Geltman, EM; Goldman, S; Gordon, D; Moyé, LA; Pfeffer, MA; Rouleau, JL | 1 |
| Kingma, JH; van Gilst, WH | 2 |
| Beil, S; Doering, W; Hinzmann, S; Kleber, FX; Kosloswki, B; Reindl, I; Rodewyk, P; Sabin, GV; Wenzel, M; Winter, UJ | 1 |
| Drexler, H; Just, H; Schulgen, G; Schumacher, M; Siegrist, J; Taylor, SH | 1 |
| Antonopoulos, AA; Georgiou, EK; Kyriakidis, MK; Marakas, SA; Michalopoulos, DA; Petropoulakis, PN; Proukakis, CC; Toutouzas, PK | 1 |
| Cardinal, R; de Champlain, J; Godin, D; Gouin, L; Moreau, P; Nadeau, R; Ribuot, C; Rochette, L; Vermeulen, M | 1 |
| Cohn, PF; Jain, P; Korlipara, G; Lillis, O; Mallavarapu, C; Sikand, V | 1 |
| Bucca, V; Cannizzaro, S; Di Pasquale, P; Paterna, S | 1 |
| Arnold, MO; Bichet, D; de Champlain, J; Hall, C; Klein, M; Moyè, L; Packer, M; Rouleau, J; Rouleau, JL; Sussex, B | 1 |
| Crozier, IG; Donald, RA; Ellis, MJ; Foy, SG; Ikram, H; Livesey, JH; Mattioli, L; Richards, AM | 1 |
| Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Gkhani, P; Lopatin, IuM; Mareev, VIu | 1 |
| Mazzotta, G; Vecchio, C | 1 |
| Luís, AS; Mourão, L; Neves, JL; Santos, AL; Santos, JM | 1 |
| Barone, G; Bucca, V; Cannizzaro, S; Di Pasquale, P; Licata, G; Paterna, S | 1 |
| Lu, CY | 1 |
| de Cesare, NB; Deboe, SF; Ellis, SG; Mancini, GB; Pitt, B; Williamson, PR | 1 |
| Gøtzsche, CO; Nøgaard, A; Ravkilde, J; Søgaard, P; Thygesen, K | 1 |
| Dagenais, GR; Goldman, S; Klein, M; Lamas, GA; Moyé, LA; Pfeffer, MA; Plappert, T; Rouleau, JL; St John Sutton, M; Sussex, B | 1 |
| Bélichard, P; Cardinal, R; Gosselin, H; Nadeau, R; Paradis, P; Rouleau, JL; Savard, P | 1 |
| Iimura, O; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Urabe, K | 1 |
| Battler, A; Leor, J; Varda-Bloom, N | 1 |
| Kopal, V; Svejda, J; Václavík, P | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Raya, TE | 1 |
| Singh, SN | 1 |
| Ganley, CJ; Hung, HM; Temple, R | 1 |
| Fenwick, MK; Kennedy, N; McAlpine, HM; Motwani, JG; Struthers, AD | 1 |
| Ambrosioni, E; Borghi, C; Boschi, S; Branzi, A; Magnani, B; Melandri, G | 1 |
| Barbosa, V; Bellotti, G; Caramelli, B; Gebara, O; Pileggi, F; Santos, RD; Tranchesi Júnior, B | 1 |
| Sharpe, N | 3 |
| Dorian, P; Newman, D | 1 |
| Lorell, BH | 1 |
| Campos-Peris, JV; Canton-Martinez, A; Castillo-Soria, FJ; Galcera-Tomas, J; Nuño de la Rosa, JA; Pico-Aracil, F; Rodriguez-Garcia, P; Ruiperez-Abizanda, JA; Ruiz-Ros, JA; Torres-Martinez, G | 1 |
| Christie, J; Cobbe, SM; Connelly, DT; Dargie, HJ; Ford, I; Morton, JJ; Northridge, DB; Oldroyd, KG; Pye, M; Ray, SG | 1 |
| Gøtzsche, CO; Ravkilde, J; Søgaard, P; Thygesen, K | 2 |
| Haghfelt, T; Thayssen, P | 1 |
| Arakawa, K; Ideishi, M; Ikeda, M; Noda, K; Sasaguri, M | 2 |
| Appleby, P; Coats, A; Collins, R; Conway, M; Flather, M; Pipilis, A; Sleight, P | 1 |
| Bucca, V; Cannizzaro, S; Di Pasquale, P; Licata, G; Maringhini, G; Parrinello, G; Paterna, S; Pipitone, F; Scalzo, S | 1 |
| Bayliss, J; Darasz, KH; Keegan, J; Poole-Wilson, PA; Sutton, GC; Underwood, SR | 1 |
| Bralet, J; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC | 1 |
| McTavish, D; Plosker, GL | 1 |
| Kobayasi, R; Sanbe, A; Takeo, S; Tanonaka, K | 1 |
| Clark, RG; Gillett, N; Jin, H; Ko, A; Paoni, NF; Yang, R | 1 |
| Goldman, S; Johnson, CS; Milavetz, JJ; Morkin, E; Raya, TE | 1 |
| Davie, AP; McMurray, JJ | 1 |
| Dambrink, JH; Kingma, JH; Peels, KH; St John Sutton, M; van Gilst, WH | 1 |
| Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP | 1 |
| Antonopoulos, A; Bakirtzis, C; Georgiou, E; Kyriakidis, M; Santas, P; Toutouzas, P | 1 |
| Deck, CC; Gaballa, MA; Raya, TE | 1 |
| Alessi, V; Bucca, V; Cannizzaro, S; D'Amato, M; Di Pasquale, P; Longo, AM; Magatti, MF; Manusia, F; Scalzo, S | 1 |
| Blokland, A; Prickaerts, J; Raaijmakers, W | 1 |
| Berger, K; Kleber, FX; Schulte-Hillen, J; Szucs, T | 1 |
| Sonntag, F | 1 |
| Kalkman, EA; Saxena, PR; Schoemaker, RG | 1 |
| Kalkman, EA; Schoemaker, RG; Smits, JF | 1 |
| Aslam, M; Niaz, MA; Rastogi, SS; Singh, RB | 1 |
| Budaj, A; Cedro, K; Ceremuzyński, L; Cybulski, J; Karczmarewicz, S; Maciejewicz, J; Wiśniewski, M | 1 |
| Iimura, O; Miki, T; Miura, T; Ogawa, T; Shimamoto, K; Suzuki, K; Ura, N | 1 |
| Arnold, JM; Ciampi, A; Klein, M; Moyé, L; Pfeffer, M; Rouleau, JL; Sussex, B; Vantrimpont, P; Wun, CC | 1 |
| O'Rourke, RA | 1 |
| Goldman, L; Lee, TH; Pfeffer, MA; Tsevat, J | 1 |
| Albano, V; Bucca, V; Di Pasquale, P; Maringhini, G; Paterna, S; Pieri, D; Scalzo, S; Valdes, L | 1 |
| Khaper, N; Singal, PK | 1 |
| Arai, H; Hirashima, O; Honda, Y; Kaikita, K; Moriyama, Y; Ogawa, H; Oshima, S; Sakamoto, T; Suefuji, H; Sumida, H; Takazoe, K; Yasue, H | 1 |
| Gong, L; Li, M; Shen, W | 1 |
| Buikema, H; Hegeman, H; van Gilst, WH; van Veldhuisen, DJ | 1 |
| de Vries, RJ; Dunselman, PH; Kingma, JH; van den Heuvel, AF; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Jugdutt, BI; Khan, MI; Lucas, A | 1 |
| Basta, L; Braunwald, E; Flaker, GC; Gersh, BJ; Lamas, GA; Mitchell, GF; Moyé, L; Pfeffer, MA; Smith, SC | 1 |
| Nakamura, M; Sonoki, H; Takeshita, A | 1 |
| Kékes, E | 1 |
| Beil, S; Doering, W; Fischer, M; Kleber, FX; Reindl, I; Sabin, GV; Wenzel, M; Winter, UJ | 1 |
| Gomes, MG; Milanez, MC; Mill, JG; Vassallo, DV | 1 |
| Bhambhani, A; Ford, WR; Jugdutt, BI; Khan, MI; Liyanage, R; Menon, V | 1 |
| Arnold, MO; Braunwald, E; Lamas, G; Moye, L; Parker, JO; Pfeffer, MA; Plappert, T; Rouleau, J; Rouleau, JL; St John Sutton, M; Sussex, B | 1 |
| Carlyle, W; Chu, C; Cohn, JN; Francis, GS; Hartman, M; Hauer, K; Judd, DL; McDonald, KM | 1 |
| Budaj, A; Ceremuzyński, L; Herbaczyńska-Cedro, K; Kokot, F | 1 |
| Cannizzaro, S; Di Pasquale, P; Iachininoto, R; Longo, AM; Maringhini, G; Paterna, S | 1 |
| Björck, JE; Dahlöf, B; de Faire, U; Hansson, L; Hedner, T; Karlberg, BE; Lanke, J; Lindholm, L; Luomanmäki, K; Mörlin, C; Niklason, A; Niskanen, L; Wester, PO | 1 |
| Davis, BR; Hager, WD; Lamas, GA; Moye, LA; Pfeffer, MA; Riba, A; Rouleau, JL; Wun, CC | 1 |
| Krakoff, LR; Rajasekharaiah, V | 1 |
| Altmann, C; Horstmann, E; Josephs, W; Konermann, M; Laschewski, F; Odenthal, HJ; Sanner, B | 1 |
| Busatto, VC; de Moraes, AC; Gomes, Mda G; Milanez, Mda C; Mill, JG | 1 |
| Anthonio, RL; Crijns, HJ; de Kam, PJ; Kingma, JH; Oosterga, M; van Gilst, WH | 1 |
| Angehrn, W; Baumann, PC; Bertel, O; Jolliet, P; Meier, B; Naegeli, B; Siegrist, P; Simeon-Dubach, D; Stauffer, JC; Urban, P; Wunderlin, R | 1 |
| Belisari, A; Mantovani, LG; Szucs, TD | 1 |
| Humen, DP; Jugdutt, BI | 1 |
| Bucca, V; Di Pasquale, P; Paterna, S; Scalzo, S | 1 |
| Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
| Kawada, T; Miyano, H; Sato, T; Shishido, T; Sugimachi, M; Sunagawa, K; Yoshimura, R | 1 |
| Bichet, D; Ciampi, A; de Champlain, J; Harel, F; Moyé, LA; Pfeffer, M; Rouleau, JL; Vantrimpont, P | 1 |
| Hartley, LH; McConnell, TR; Menapace, FJ; Pfeffer, MA | 1 |
| Tang, C; Zeng, X; Zhang, J | 1 |
| El Salibi, E; Nguyen, T; Rouleau, JL | 1 |
| Daemen, MJ; Kuizinga, MC; Nelissen-Vrancken, HJ; Smits, JF | 1 |
| Arai, H; Hirai, N; Misumi, K; Moriyama, Y; Nishiyama, K; Ogawa, H; Oshima, S; Shimomura, H; Soejima, H; Suefuji, H; Takazoe, K; Yasue, H | 1 |
| Amos, DJ; Ashton, NG; Cross, DB; Elliott, JM; French, JK; Hart, HH; McLaughlin, SC; Norris, RM; White, HD; Whitlock, RM; Williams, BF; Williams, MG | 1 |
| Björck, JE; Dahlöf, B; de Faire, U; Hansson, L; Hedner, T; Karlberg, BE; Lanke, J; Lindholm, LH; Luomanmäki, K; Mörlin, C; Niklason, A; Niskanen, L; Wester, PO | 1 |
| Davie, AP | 1 |
| Bottero, G; Ceci, V; Coletta, C; Mazzuca, V; Pasquale, M; Putini, RL; Ricci, R; Rulli, F; Salustri, A; Seccareccia, F | 1 |
| Wesley, D | 1 |
| Kalkman, EA; Saxena, PR; Schoemaker, RG; van Haren, P | 1 |
| Chen, HZ; Peng, TQ; Pu, SY; Shen, XD; Yang, YZ; Zhang, GX | 1 |
| Bounhoure, JP; Dubourg, O; Guéret, P; Thuillez, C; Vahanian, A | 1 |
| Bucca, V; Cannizzaro, S; Di Pasquale, P; Giubilato, A; Paterna, S; Scalzo, S | 1 |
| Gong, L; Hu, H; Li, M; Shen, W; Zhang, X | 1 |
| Chen, JJ; Chen, SF; Cherng, WJ; Lee, N; Wang, CH | 1 |
| Ambrosioni, E; Bacchelli, S; Bignamini, A; Borghi, C; Esposti, DD; Magnani, B | 1 |
| Anguera, I; Escolar, G; Heras, M; Lozano, M; Roig, E; Sanz, G; Zurbano, MJ | 1 |
| Dhalla, NS; Ganguly, PK; Ren, B; Shao, Q; Zarain-Herzberg, A | 1 |
| Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA | 1 |
| Di Pasquale, P; Paterna, S | 1 |
| Andries, L; Azad, A; Brutsaert, DL; Gosselin, H; Picard, P; Qi, XL; Rouleau, JL; Stewart, DJ; Sys, SU | 1 |
| Litwin, SE; Morgan, JP | 2 |
| Kim, HS; Oh, BH; Youn, TJ | 1 |
| de Groot, M; Dienesch, C; Ertl, G; Horn, M; Hu, K; Hügel, S; Neubauer, S; Remkes, H | 1 |
| Agelopoulos, G; Alexopoulos, D; Chiladakis, JA; Karapanos, G; Manolis, AS | 1 |
| Chida, M; Fukuchi, M; Ido, T; Kagaya, Y; Namiuchi, S; Shirato, K; Takahashi, C; Tezuka, F; Watanabe, J; Yamane, Y | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Lee, RJ; Parmley, WW; Pulukurthy, S; Sievers, RE; Sudhir, K; Sun, Y; Zhu, B | 1 |
| Andrews, J; French, JK; Manda, SO; White, HD | 1 |
| Fischerova, B; Pluhacek, L; Spinar, J; Spinarova, L; Toman, J; Vitovec, J | 2 |
| Genoni, M; Maggioni, AP; Malacrida, R; Moccetti, T; Sessa, F; Siegrist, P | 1 |
| Hayashi, Y; Hoshiai, K; Hoshiai, M; Ishida, H; Kanno, T; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Nakazawa, H; Tajima, K | 1 |
| Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
| Armstrong, PW | 1 |
| Dvorak, SR | 1 |
| Luft, FC | 1 |
| Alderman, M; Furberg, CD; Kuller, LH; Pahor, M; Psaty, BM | 1 |
| Boomsma, F; Danser, AH; Duncker, DJ; Haitsma, DB; Niebuur, R; Schalekamp, MA; Schuijt, MP; Stubenitsky, R; van Kats, JP; Verdouw, PD | 1 |
| Altmann, C; Konermann, M; Laschewski, F; Odenthal, HJ; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
| Califf, R; Edwards, S; Gallo, P; Henis, M; Leizorovicz, A; Maggioni, AP; McMurray, J; Neuhart, E; Pfeffer, MA; Rouleau, JL; Sellers, MA; Van De Werf, F; Velazquez, E | 1 |
| Filipiak, J; Ozegowski, S; Poprawski, K; Sieńko, A; Szymanowska, K; Wierzchowiecki, M | 1 |
| Balding, LC; Burrell, LM; Farina, NK; Johnston, CI | 1 |
| Awad, TA; de Feo , G; Jin, H; Li, W; Ogasawara, A; Paoni, NF; Shimada, B; Wang, F; Williams, PM; Williams, SP; Yang, R | 1 |
| Castillo-Soria, FJ; de La Rosa, JA; Florenciano-Sánchez, R; Galcerá-Tomás, J; Iñigo-García, L; Jara-Pérez, P; López-Martínez, I; Martínez-Caballero, A; Párraga-Ramírez, M; Picó-Aracil, F; Sánchez-Villanueva, JG; Valentí-Aldeguer, JA; Villegas-García, MM | 1 |
| Alessi, V; Barberi, O; Bucca, V; Di Pasquale, P; Maringhini, G; Paterna, S; Scalzo, S; Scandurra, A | 1 |
| Cannizzaro, S; Di Pasquale, P; Giambanco, F; Giubilato, A; Paterna, S; Saccone, G; Sarullo, FM; Scandurra, A; Vitrano, MG | 1 |
| Bässler, A; Fischer, M; Hengstenberg, C; Holmer, S; Klein, G; Löwel, H; Mayer, B; Riegger, G; Schunkert, H | 1 |
| Francis, GS; Gassler, JP | 1 |
| Haas, GJ | 1 |
| Altmann, C; Konermann, M; Laschewski, F; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
| Mazur, NA; Vikent'ev, VV | 1 |
| Henze, E; Hetzel, J; Hetzel, M; Hombach, V; Wieshammer, S | 1 |
| Goto, K; Kagaya, Y; Kondo, H; Ohta, J; Shirato, K; Sugie, T; Takahashi, J; Takeda, M; Watanabe, J | 1 |
| Bottero, G; Ceci, V; Coletta, C; Pajes, G; Pasquale, M; Putini, RL; Ricci, R; Salustri, A | 1 |
| Chen, H; Pan, W; Pu, S; Shen, X; Yang, Y; Zhang, G | 1 |
| Hansson, L; Hedner, T; Lanke, J; Niklason, A; Niskanen, L | 1 |
| Liu, L | 1 |
| Cai, X; Gong, L; Shen, W | 1 |
| Chaupin, DF; Christie, RM; Daniel, SL; Entman, ML; Gould, KE; Hartley, CJ; Konkol, DL; Michael, LH; Pocius, JS; Sandusky, GE; Taffet, GE; Zachariah, JP | 1 |
| Chan, KK; Chen, WH; Keung, KK; Lau, CP; Lau, YK; Leung, SK; Li, SK; Ng, W; Tang, YW; Tse, HF | 1 |
| Liu, Z; Wang, J; Yang, S | 1 |
| Remme, WJ | 1 |
| Cannizzaro, S; Di Pasquale, P; Giubilato, A; Paterna, S; Scalzo, S; Scandurra, A | 1 |
| Andrews, J; French, JK; Manda, SO; McTigue, JJ; Stewart, RA; White, HD | 1 |
| Charbonnier, B; Dubroca, I; Etienne, S; Normand, J; Ounnoughene, Z; Schwob, J; Vaur, L; Weber, S | 1 |
| Akhmetova, AS; Teĭblium, MM; Zaslavskaia, RM; Zhamankulov, KZh | 1 |
| Adam, A; Bachvarov, DR; Blais, C; Clément, R; Lapointe, N; Rouleau, JL | 1 |
| Bryl, ZV; Irkin, OI; Kushnir, SP; Parkhomenko, AN; Shkliar, LV; Soliarik, O | 1 |
| Kovacs, L; Simko, F; Simková, M | 1 |
| Ghosh, MB; Guha, S; Hazra, BR; Rakshit, K; Roy, BP | 1 |
| Adam, A; Blais, C; Clément, R; Gosselin, H; Lapointe, N; Parker, T; Rouleau, JL; Sirois, MG | 1 |
| Juszczak, A; Krzyś, T; Michalski, M; Michałowicz, B; Poprawski, K; Sieńko, A; Szymanowska, K; Wierzchowiecki, M | 1 |
| Arakawa, K; Kawano, T; Nakashima, Y; Nii, T | 1 |
| Albano, V; Barone, G; Cannizzaro, S; Di Pasquale, P; Licata, G; Paterna, S; Valdes, L | 1 |
| Doering, W; Kleber, FX; Niemöller, L; Nussberger, J | 1 |
| Zhang, JH | 1 |
| Albano, V; Albiero, R; Di Pasquale, P; Licata, G; Paterna, S; Trombino, G; Valdes, L; Valenza, M; Vitrano, G | 1 |
| Foster, S; Goldman, S; Lee, RW; Meeks, T; Michael, U; Raya, TE | 1 |
| Nelissen-Vrancken, HJ; Smits, JF; Struijker-Boudier, HA | 1 |
| de Lorgeril, M; Delaye, J; Ovize, M; Renaud, S | 1 |
| Bartels, H; de Graeff, PA; de Langen, CD; Monnink, SH; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Basta, L; Braunwald, E; Brown, EJ; Cuddy, TE; Davis, BR; Flaker, GC; Geltman, EM; Goldman, S; Moyé, LA; Pfeffer, MA | 1 |
| Anversa, P; Capasso, JM | 1 |
| Anversa, P; Bruno, S; Capasso, JM; Cheng, W; Darzynkiewicz, Z; Li, P; Rodgers, R | 1 |
| Boon, NA; Flint, LL; Hargreaves, AD; Jacob, AJ; Kolettis, T; Muir, AL; Turnbull, LW | 1 |
| Deck, CC; Gaballa, MA; Goldman, S; Raya, TE | 1 |
| Cohn, JN | 1 |
| Arrichiello, P; Attisano, T; Bianchi, V; Bonaduce, D; Condorelli, M; Morgano, G; Petretta, M; Rotondi, F | 1 |
| Arrichiello, P; Attisano, T; Bianchi, V; Bonaduce, D; Conforti, G; Montemurro, MV; Morgano, G; Petretta, M | 1 |
| Lamas, GA; Mitchell, GF; Pfeffer, MA; Vaughan, DE | 1 |
| Braunwald, E; Hamm, P; Lamas, GA; Pfeffer, MA; Rouleau, JL; Wertheimer, J | 1 |
| Jugdutt, BI; Khan, MI; Schwarz-Michorowski, BL | 1 |
| Donohue, TJ; Kern, MJ | 1 |
| Kumar, PD | 1 |
| Humen, DP; Jugdutt, BI; Khan, MI; Schwarz-Michorowski, BL | 1 |
| Howard, PA | 1 |
| Andrés, F; Cosín, J; Hernándiz, A; Rivera, M; Solaz, J | 1 |
| Jiang, M | 1 |
| Gamble, G; Greaves, S; Hart, H; Murphy, J; Sharpe, N; Smith, H | 1 |
| Doering, W; Fischer, M; Kleber, FX; Niemöller, L | 1 |
| Goldman, S; Litwin, CM; Litwin, SE; Raya, TE; Warner, A | 1 |
| Belousov, IuB; Pinzur, SV | 2 |
| Bosman, FT; Cleutjens, JP; Daemen, MJ; Debets, JJ; Schoemaker, RG; Smits, JF; Struyker Boudier, HA; van Krimpen, C | 1 |
| de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Bates, ER; Ellis, SG; Galeana, A; Muller, DW; Nabel, EG; Pitt, B; Schwaiger, M; Topol, EJ; Walton, JA; Werns, SW | 1 |
| Bosman, FT; Cleutjens, JP; Daemen, MJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA; van Krimpen, C | 1 |
| de Graeff, PA; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Pfeffer, JM | 1 |
| Braunwald, E; Moyé, LA; Pfeffer, MA | 1 |
| Brunner, H; Doering, W; Kleber, FX; Niemöller, L; Nussberger, J | 1 |
| Daugherty, S; Fonken, SJ; Goldman, S; Lee, RW; Morkin, E; Raya, TE; Timmermans, PB; Wong, PC | 1 |
| Lema-Santos, A; Mourão, L; Neves, JL; Sales-Luís, A; Santos, JM | 1 |
| Ribeiro, C | 1 |
| Christie, J; Cobbe, SM; Dargie, HJ; Ford, I; Oldroyd, KG; Pye, MP; Ray, SG | 1 |
| Das, DK; Engelman, RM; Iyengar, J; Rousou, JA | 1 |
| Goldman, S; Litwin, CM; Litwin, SE; Raya, TE; Warner, AL | 1 |
| Debets, JJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA | 1 |
| Bel, KJ; de Graeff, PA; de Langen, CD; Mook, PH; Tio, RA; van Gilst, WH; van Wijngaarden, J; Wesseling, H; Wolters, KG | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Barone, G; Cannizzaro, S; Di Pasquale, P; Giubilato, A; Paterna, S | 1 |
| Parker, BM; Sharaf el-Deane, MS | 1 |
| Hannan, S; Murphy, J; Sharpe, N; Smith, H | 2 |
| Gallet, B; Hiltgen, M | 1 |
| Kloner, RA; Mehta, PM; Przyklenk, K | 1 |
| Eilles, C; Ertl, G; Gaudron, P | 1 |
| Gay, RG | 1 |
| Bech, OM; Diamant, B; Jensen, MK; Steiness, E; Sørensen, JD | 1 |
| Dargie, HJ; Leckie, B; McAlpine, HM; Morton, JJ | 1 |
| Bel, KJ; de Graeff, PA; de Langen, CD; Kingma, JH; van Gilst, WH; Wesseling, H | 1 |
| Lamas, GA | 1 |
| Tikkanen, T | 1 |
| Aguirre, M; Gay, RG; Goldman, S; Raya, TE | 1 |
| Lamas, GA; Parisi, AF; Pfeffer, MA; Vaughan, DE | 1 |
| Emchenko, IR; Iaremenko, OB; Kurochko, VB; Netiazhenko, VZ | 1 |
| Chen, X; Li, K | 1 |
| Ribuot, C; Rochette, L | 1 |
| Perry, HM | 1 |
| Pitt, B | 1 |
| Alker, KJ; Kloner, RA; Mehta, PM | 1 |
| Braunwald, E; Lamas, GA; Parisi, AF; Pfeffer, MA; Vaughan, DE | 1 |
| Chobanian, AV | 1 |
| Pfeffer, JM; Pfeffer, MA | 1 |
| Cobbe, SM; McAlpine, HM | 1 |
| Morozova, TE; Ol'binskaia, LI | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| de Graeff, PA; de Langen, CD; Kingma, JH; van Binsbergen, E; van Gilst, WH; Wesseling, H | 1 |
| Cappello, C; Fusaro, MT; Mattioli, G; Ricci, S; Rigo, R | 1 |
| Braunwald, E; Pfeffer, JM; Pfeffer, MA | 2 |
| Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, P; Sutton, G | 1 |
| Depenbusch, JW; Drexler, H; Flaim, SF; Truog, AG; Zelis, R | 1 |
| Drexler, H; Just, H; Truog, AG; Zelis, R | 1 |
| Finn, P; Pfeffer, JM; Pfeffer, MA; Steinberg, C | 1 |
45 review(s) available for captopril and Cardiovascular Stroke
| Article | Year |
|---|---|
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Xanthine Oxidase | 2018 |
Evolving concept of cardioprotection in myocardial infarction: from SMILE-1 to SMILE-5.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2013 |
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Control
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
[The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Heart Failure; Humans; Indoles; Middle Aged; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Ventricular Dysfunction | 2008 |
[Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diabetic Cardiomyopathies; Heart Failure; Humans; Hypertension; Myocardial Infarction | 2011 |
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Acute myocardial infarction].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Coronary Restenosis; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan | 2002 |
[Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Survival Rate; Treatment Outcome | 2003 |
[Preventive therapy with ACE inhibitors for coronary patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Enalapril; Humans; Indoles; Lisinopril; Myocardial Infarction; Perindopril; Ramipril; Treatment Outcome | 2004 |
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Heart; Humans; Hypertension; Myocardial Infarction | 2004 |
[Assessment of natriuretic peptides levels in the study of efficacy of perindopril and captopril in myocardial infarction with systolic dysfunction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Humans; Myocardial Infarction; Natriuretic Peptides; Perindopril | 2005 |
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Captopril; Cardiovascular Diseases; Enalapril; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Ventricular Dysfunction | 2005 |
[Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Time Factors; Treatment Outcome | 2006 |
Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia | 2006 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Right ventricular function: methodologic and clinical considerations in noninvasive scintigraphic assessment.
Topics: Animals; Captopril; Coronary Disease; Echocardiography; Heart; Heart Defects, Congenital; Heart Ventricles; Humans; Lung Diseases; Myocardial Infarction; Nitroglycerin; Nitroprusside; Pericardial Effusion; Prazosin; Radioisotopes; Radionuclide Imaging; Thallium | 1984 |
[Role of converting enzyme inhibitors in myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic | 1995 |
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction | 1994 |
Postmyocardial infarction patients: experience from the SAVE trial.
Topics: Captopril; Decision Trees; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 1995 |
[Secondary prevention after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Captopril; Humans; Myocardial Infarction | 1993 |
Effects of ACE inhibitors on coronary haemodynamics and angina pectoris.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Enalaprilat; Hemodynamics; Humans; Hypertension; Myocardial Infarction | 1994 |
[Use of captopril and other angiotensin-converting enzyme inhibitors in patients with myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Myocardial Infarction; Renin-Angiotensin System; Treatment Outcome; Vasodilation | 1993 |
[Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Injections, Intravenous; Lisinopril; Male; Multicenter Studies as Topic; Myocardial Infarction; Nitroglycerin; Ramipril; Thrombolytic Therapy; Time Factors | 1994 |
[Captopril: a new drug for myocardial ischemia and infarction?].
Topics: Captopril; Humans; Myocardial Infarction; Myocardial Ischemia | 1993 |
Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Myocardial Infarction; Myocardial Ischemia | 1995 |
[Captopril in the treatment of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents | 1997 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
ACE inhibitors: new hope for old drugs?
Topics: Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Ramipril; Risk Factors | 2000 |
Angiotensin-converting enzyme inhibitors in antihypertensive therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Humans; Hypertension; Myocardial Infarction; Ramipril; Risk Factors | 2000 |
Management of asymptomatic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
[The ACE inhibitor, captopril, in the light of new clinical studies].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Heart Failure; Humans; Myocardial Infarction | 2002 |
Studies of left ventricular dysfunction following myocardial infarction.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Substance Withdrawal Syndrome; Ventricular Function, Left | 1991 |
Early preventive treatment of left ventricular dysfunction following myocardial infarction: optimal timing and patient selection.
Topics: Captopril; Cardiomegaly; Humans; Myocardial Infarction; Time Factors; Ventricular Function, Left | 1991 |
[Angiotensin I converting enzyme inhibitors in ischemic cardiopathy].
Topics: Angina Pectoris; Angiotensin I; Captopril; Clinical Trials as Topic; Coronary Circulation; Myocardial Infarction | 1991 |
Postinfarction cardiac dilatation. Is it modifiable?
Topics: Animals; Captopril; Cardiomegaly; Humans; Myocardial Contraction; Myocardial Infarction; Nifedipine; Nitroglycerin | 1990 |
[Expansion and remodelling of the left ventricle after myocardial infarction].
Topics: Animals; Captopril; Cardiomegaly; Humans; Myocardial Infarction; Risk Factors; Time Factors | 1990 |
Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction.
Topics: Animals; Captopril; Coronary Disease; Humans; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury | 1990 |
[Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction | 1990 |
[Use of captopril in myocardial infarct].
Topics: Captopril; Hemodynamics; Humans; Myocardial Infarction; Vasodilator Agents | 1990 |
Left ventricular dilatation following myocardial infarction: clinical course and potential for therapy.
Topics: Animals; Captopril; Cardiomegaly; Humans; Myocardial Contraction; Myocardial Infarction; Time Factors | 1989 |
ACE inhibitors after myocardial infarction.
Topics: Captopril; Cardiomegaly; Cardiomyopathy, Dilated; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume | 1989 |
The evolution of antihypertensive therapy.
Topics: Antihypertensive Agents; Bis-Trimethylammonium Compounds; Blood Pressure; Calcium Channel Blockers; Captopril; Chlorothiazide; Diuretics; Follow-Up Studies; Hexamethonium; Hexamethonium Compounds; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; Myocardial Infarction; Reserpine; Risk; Sodium Chloride Symporter Inhibitors; Time Factors | 1985 |
198 trial(s) available for captopril and Cardiovascular Stroke
| Article | Year |
|---|---|
Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies.
Topics: Aged; Amlodipine; Antihypertensive Agents; Captopril; Data Analysis; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Time-to-Treatment; Treatment Outcome | 2018 |
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Myocardial Infarction; Quality of Life; Recurrence; Stroke; Survivors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Sex Factors; Valsartan; Ventricular Dysfunction, Left | 2015 |
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Topics: Captopril; Demography; Drug Therapy, Combination; Endpoint Determination; Female; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Myocardial Infarction; Propensity Score; Ramipril; Survival Analysis; Time Factors; Ventricular Dysfunction, Left | 2016 |
Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors | 2017 |
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Comorbidity; Female; Heart Failure; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction | 2008 |
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cholesterol, LDL; Diagnostic Tests, Routine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Time Factors; Treatment Outcome | 2009 |
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2010 |
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Topics: Age Factors; Aged; Captopril; Cause of Death; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2011 |
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Monitoring, Physiologic; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Reference Values; Reproducibility of Results; Risk Assessment; ROC Curve; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hypertrophy, Left Ventricular; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Prospective Studies; Renin-Angiotensin System; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Valine; Valsartan | 2012 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Endpoint Determination; Female; Humans; Losartan; Male; Middle Aged; Morbidity; Myocardial Infarction; Risk Factors | 2002 |
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Hypotension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Recurrence; Survival Rate | 2003 |
ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Losartan; Male; Myocardial Infarction; Receptor, Angiotensin, Type 1; Research Design; Risk Assessment | 2003 |
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Prognosis | 2003 |
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiomegaly; Demography; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Premature Complexes; Ventricular Remodeling | 2003 |
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis; Time Factors | 2003 |
Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Radionuclide Ventriculography; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Electrocardiography; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 2004 |
[AT(1) blocker for post-infarct therapy. VALIANT Study].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Syndrome; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
[Results of the VALIANT trial in post-myocardial infarction].
Topics: Adult; Aftercare; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Captopril; Cause of Death; Coronary Angiography; Double-Blind Method; Echocardiography; Female; Hospitalization; Humans; Male; Myocardial Infarction; Patient Selection; Proportional Hazards Models; Risk Factors; Stroke Volume; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2004 |
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survivors; Ventricular Dysfunction, Left | 2004 |
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Chronic Disease; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survival Rate; Tetrazoles; Valine; Valsartan | 2004 |
Heart attack patients with complications. Treat with valsartan, captopril, or both?
Topics: Aged; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Captopril; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heart Function Tests; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Risk | 2004 |
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Captopril; Epidemiologic Methods; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke; Ventricular Dysfunction, Left | 2005 |
Soluble CD40 ligand in acute and chronic heart failure.
Topics: Acute Disease; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; CD40 Ligand; Chronic Disease; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2005 |
VALIANT (VALsartan In Acute myocardial iNfarcTion) trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan | 2005 |
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Hospitalization; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke Volume; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
[Randomized multicenter study PRESTIGE: assessment of efficacy of perindopril as compared with captopril in patients with acute myocardial infarction with left ventricular dysfunction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Male; Myocardial Infarction; Perindopril; Ventricular Dysfunction, Left | 2005 |
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Ambulatory Care; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Costs; Global Health; Health Care Costs; Health Resources; Heart Failure; Hospital Costs; Hospitalization; Humans; Myocardial Infarction; Prospective Studies; Quality of Life; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarct
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Captopril; Cardiovascular Diseases; Cause of Death; Heart Failure; Humans; Middle Aged; Morbidity; Mortality; Myocardial Infarction; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Captopril; Cardiac Output, Low; Female; Humans; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2006 |
Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 2006 |
Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 2007 |
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Research Design; Risk Factors; Stroke Volume; Survival Analysis; Survivors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Ventricles; Humans; Losartan; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Severity of Illness Index; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
Topics: Aged; Amiodarone; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction | 2008 |
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Diabetes Complications; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Test; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function | 1995 |
Acute effect of captopril administration on baroreflex sensitivity in patients with acute myocardial infarction.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Electrocardiography; Female; Hemodynamics; Humans; Male; Myocardial Infarction; Pressoreceptors; Reflex; Sympathetic Nervous System; Vagus Nerve | 1995 |
Cost-effectiveness analysis and clinical practice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Humans; Middle Aged; Myocardial Infarction | 1995 |
Cost-effectiveness of captopril therapy after myocardial infarction.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Boston; Captopril; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Female; Hospitals, Teaching; Humans; Male; Markov Chains; Middle Aged; Myocardial Infarction; Quality-Adjusted Life Years; Stroke Volume; Value of Life | 1995 |
Captopril in acute myocardial infarction: beneficial effects on infarct size and arrhythmias.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Enzyme Tests; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Thrombolytic Therapy; Vasodilator Agents; Ventricular Fibrillation; Ventricular Premature Complexes | 1995 |
Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Creatine Kinase; Double-Blind Method; Enalapril; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Stroke Volume | 1995 |
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
Topics: Adrenergic beta-Antagonists; Captopril; Cardiac Catheterization; Coronary Vessels; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Stroke Volume; Survival Analysis; Time Factors; Vascular Patency; Ventricular Dysfunction, Left | 1995 |
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Magnesium Sulfate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Vasodilator Agents | 1995 |
Effects of captopril on plasma endothelin-1 during thrombolysis: preliminary findings.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Endothelins; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Recombinant Proteins; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1995 |
Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Captopril; Cardiac Complexes, Premature; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Tachycardia, Ventricular | 1993 |
[Cost-effectiveness analysis of captopril treatment after myocardial infarction].
Topics: Captopril; Cost-Benefit Analysis; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Placebos; Prospective Studies; Recurrence; Treatment Outcome | 1994 |
Effects of administration of captopril, metoprolol, and the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction.
Topics: Captopril; Drug Combinations; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Single-Blind Method; Thrombolytic Therapy | 1994 |
Special report on the ISIS-4 study.
Topics: Captopril; Drug Administration Schedule; Humans; International Cooperation; Magnesium Sulfate; Myocardial Infarction; Nitrates; Survival Analysis | 1995 |
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Captopril; Cross-Over Studies; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuresis; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sodium; Ultrasonography; Ventricular Dysfunction, Left | 1995 |
Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators.
Topics: Alleles; Captopril; Double-Blind Method; Female; Follow-Up Studies; Gene Deletion; Homozygote; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Peptidyl-Dipeptidase A; Prospective Studies; Streptokinase; Thrombolytic Therapy; Time Factors; Ultrasonography | 1995 |
Early intravenous magnesium administration in acute myocardial infarction.
Topics: Animals; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Infusions, Intravenous; Magnesium Chloride; Magnesium Sulfate; Myocardial Infarction; Nitrates; Thrombolytic Therapy; Treatment Outcome | 1994 |
Effects of the administration of captopril, metoprolol and of the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction.
Topics: Aged; Captopril; Chemotherapy, Adjuvant; Creatine Kinase; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Stroke Volume; Survival Rate; Tachycardia, Ventricular; Thrombolytic Therapy; Time Factors | 1994 |
Mechanistic lessons from the SAVE Study. Survival and Ventricular Enlargement.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Humans; Myocardial Infarction; Recurrence; Survival Analysis; Ventricular Dysfunction, Left | 1994 |
Association between reduced heart rate variability and left ventricular dilatation in patients with a first anterior myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study.
Topics: Captopril; Dilatation, Pathologic; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Streptokinase; Thrombolytic Therapy | 1994 |
Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; China; Drug Therapy, Combination; Humans; Myocardial Infarction; Placebos | 1995 |
Captopril in acute myocardial infarction. Beneficial effects on infarct size and arrhythmias.
Topics: Arrhythmias, Cardiac; Captopril; Double-Blind Method; Echocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1995 |
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Captopril; Cardiac Output, Low; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Morbidity; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Stroke Volume; Survival Rate; Time Factors; Ventricular Function, Left | 1993 |
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
Topics: Aged; Aldosterone; Analysis of Variance; Arginine Vasopressin; Atrial Natriuretic Factor; Canada; Captopril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Prognosis; Proportional Hazards Models; Renin | 1994 |
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
Topics: Angina, Unstable; Captopril; Cardiomegaly; Double-Blind Method; Hospitalization; Humans; Incidence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Placebos; Recurrence; Risk Factors; Survival Analysis | 1994 |
Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS).
Topics: Captopril; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Norepinephrine; Radionuclide Ventriculography; Streptokinase; Thrombolytic Therapy; Ventricular Dysfunction, Left | 1994 |
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction; Treatment Outcome | 1995 |
Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
Topics: Aged; Blood Flow Velocity; Captopril; Cardiac Output, Low; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Iodohippuric Acid; Kidney; Male; Middle Aged; Myocardial Infarction; p-Aminohippuric Acid; Premedication; Regional Blood Flow; Single-Blind Method | 1994 |
Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.
Topics: Captopril; Depression, Chemical; Double-Blind Method; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Plasminogen Activator Inhibitor 1; Statistics as Topic; Time Factors; Tissue Plasminogen Activator | 1994 |
Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril.
Topics: Acute Disease; Arrhythmias, Cardiac; Captopril; Chronic Disease; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 1994 |
Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome | 1994 |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial.
Topics: Adult; Aged; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Quality of Life; Survivors; Ventricular Function, Left | 1994 |
Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilo
Topics: Captopril; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Magnesium Sulfate; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Pilot Projects; Research Design; Safety; Time Factors; Vasodilator Agents | 1994 |
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study.
Topics: Captopril; Cohort Studies; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Hypertrophy, Left Ventricular; Life Tables; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1994 |
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
Topics: Adult; Aged; Atrial Natriuretic Factor; Captopril; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Prospective Studies; Sensitivity and Specificity; Stroke Volume; Ventricular Function, Left | 1993 |
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators.
Topics: Angina Pectoris; Canada; Captopril; Coronary Angiography; Coronary Care Units; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Revascularization; Practice Patterns, Physicians'; Quality of Health Care; Random Allocation; Recurrence; Treatment Outcome; United States | 1993 |
Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study (CATS).
Topics: Adult; Aged; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Streptokinase; Survival Rate; Thrombolytic Therapy | 1993 |
The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
Topics: Adult; Aged; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Proportional Hazards Models; Survival Rate; Ventricular Function, Left | 1993 |
Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
Topics: Adult; Aged; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Pilot Projects; Recurrence; Survival Rate | 1993 |
Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Topics: Adult; Aged; Angina Pectoris; Captopril; Coronary Disease; Digoxin; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Quality of Life; Survival Rate | 1993 |
The effects of early captopril treatment on left ventricular volumes and function in patients with and without depressed global ejection fraction after acute myocardial infarction.
Topics: Captopril; Coronary Angiography; Female; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Ventricular Function, Left | 1993 |
Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects.
Topics: Arrhythmias, Cardiac; Captopril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Reperfusion Injury; Thrombolytic Therapy; Time Factors | 1994 |
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
Topics: Atrial Natriuretic Factor; Captopril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peptide Fragments; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Risk Factors; Time Factors | 1994 |
Exercise capacity in patients with left ventricular dysfunction following acute myocardial infarction: relation to systolic and diastolic function and intervention with captopril.
Topics: Captopril; Cardiac Volume; Diastole; Double-Blind Method; Exercise Tolerance; Humans; Male; Middle Aged; Myocardial Infarction; Systole; Ventricular Function, Left | 1994 |
Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
Topics: Adrenocorticotropic Hormone; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Captopril; Corticotropin-Releasing Hormone; Double-Blind Method; Enalapril; Female; Humans; Hydrocortisone; Male; Myocardial Infarction | 1994 |
[Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Angiotensin II; Baroreflex; Captopril; Cardiac Output, Low; Chronic Disease; Digoxin; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Sclerosis; Stroke Volume; Time Factors | 1993 |
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
Topics: Aged; Angiotensin II; Blood Pressure; Captopril; Cardiac Volume; Cause of Death; Double-Blind Method; Drug Tolerance; Enalapril; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Stroke Volume; Survival Rate; Ventricular Function, Left | 1994 |
[The evaluation of the hemodynamic effects of captopril one year after a myocardial infarct].
Topics: Adult; Aged; Aspirin; Captopril; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Portugal; Time Factors | 1994 |
[Captopril administration before thrombolysis in patients with an acute myocardial infarct: a pilot study of the short- and long-term effects].
Topics: Captopril; Chi-Square Distribution; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Single-Blind Method; Thrombolytic Therapy; Time Factors; Urokinase-Type Plasminogen Activator | 1993 |
[Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study].
Topics: Angiotensin II; Blood Pressure; Captopril; Double-Blind Method; Humans; Myocardial Infarction | 1993 |
Early reocclusion after successful thrombolysis is related to lesion length and roughness.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Captopril; Combined Modality Therapy; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Myocardial Infarction; Radiographic Image Interpretation, Computer-Assisted; Recurrence; Risk Factors; Surface Properties; Thrombolytic Therapy; Tissue Plasminogen Activator | 1993 |
Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction.
Topics: Captopril; Cardiac Volume; Double-Blind Method; Electrocardiography; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Ultrasonography; Ventricular Function, Left | 1994 |
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
Topics: Captopril; Echocardiography; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Time Factors; Ventricular Function, Left | 1994 |
Effectiveness of captopril in reversing renal vasoconstriction after Q-wave acute myocardial infarction.
Topics: Aged; Analysis of Variance; Captopril; Chi-Square Distribution; Electrocardiography; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Renal Circulation; Time Factors; Vasoconstriction | 1993 |
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Renin; Renin-Angiotensin System | 1993 |
Early administration of captopril and nitroglycerin in combination after acute myocardial infarction: an invasive haemodynamic study.
Topics: Adult; Captopril; Cardiac Catheterization; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Thrombolytic Therapy | 1993 |
Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.
Topics: Acute Disease; Adult; Aged; Captopril; Double-Blind Method; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome; Ventricular Function, Left | 1993 |
Early treatment with captopril after acute myocardial infarction.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Captopril; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Vascular Resistance | 1993 |
Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction.
Topics: Captopril; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Ventricular Function, Left | 1993 |
Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.
Topics: Aged; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pilot Projects | 1993 |
Captopril does not affect plasma endothelin-1 during thrombolysis and reperfusion.
Topics: Administration, Oral; Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatine Kinase; Double-Blind Method; Electrocardiography; Endothelins; Female; Heart Rate; Humans; Isoenzymes; Male; Myocardial Infarction; Myocardial Reperfusion; Placebos; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1995 |
Left ventricular volume in thrombolysed patients with acute anterior myocardial infarction: the effect of captopril and xamoterol.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Volume; Cardiotonic Agents; Dilatation, Pathologic; Double-Blind Method; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Placebos; Prospective Studies; Stroke Volume; Thrombolytic Therapy; Ventricular Dysfunction, Left; Ventricular Function, Left; Xamoterol | 1995 |
Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors; Treatment Outcome | 1996 |
Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prevalence; Prospective Studies; Time Factors | 1996 |
Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Chemotherapy, Adjuvant; Coronary Angiography; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 1996 |
[Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?].
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Double-Blind Method; Endothelin-1; Female; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Time Factors | 1996 |
[Cost effectiveness of captopril after myocardial infarct; comment].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1996 |
Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction. Randomized, placebo-controlled substudy of ISIS-4.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Myocardial Infarction; Renin-Angiotensin System; Sympathetic Nervous System; Tachycardia, Ventricular; Treatment Outcome | 1996 |
Early captopril treatment reduces plasma endothelin concentrations in the acute and subacute phases of myocardial infarction: a pilot study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Endothelins; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects | 1997 |
Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 1997 |
Beneficial effects of captopril on prognosis in patients with acute myocardial infarction. Shanghai Secondary Prevention of Acute Myocardial Infarction Study Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction; Plasminogen Activators; Prospective Studies; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1996 |
Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Substance Withdrawal Syndrome | 1997 |
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators.
Topics: Aged; Captopril; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Double-Blind Method; Female; Forecasting; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Ventricular Function, Left | 1997 |
Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Carbon Dioxide; Cardiomegaly; Double-Blind Method; Echocardiography; Exercise Test; Female; Germany; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen Consumption; Treatment Outcome | 1997 |
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
Topics: Captopril; Cardiovascular Diseases; Echocardiography; Forecasting; Humans; Myocardial Infarction; Survival Analysis; Time Factors; Ventricular Function, Left | 1997 |
Effect of early captopril treatment on blood adrenaline levels in acute myocardial infarction (the substudy of ISIS-4). International Study of Infarct Survival-4.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Epinephrine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Renin; Sympathetic Nervous System | 1998 |
Captopril plus losartan in early post-infarction. Neurohormonal effects: a pilot study.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Pilot Projects; Single-Blind Method; Time Factors | 1997 |
The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Data Interpretation, Statistical; Female; Finland; Genes; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prospective Studies; Sweden | 1997 |
Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Organ Size; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 1998 |
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Female; Humans; Hydroxybutyrate Dehydrogenase; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ventricular Function, Left | 1998 |
Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Double-Blind Method; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Ultrasonography, Doppler; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Neurotransmitter Agents; Pilot Projects; Single-Blind Method | 1998 |
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain | 1998 |
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain | 1998 |
Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction | 1997 |
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prognosis; Prospective Studies; Renin; Survival Rate | 1998 |
Captopril reduces the VE/VCO2 ratio in myocardial infarction patients with low ejection fraction.
Topics: Anaerobic Threshold; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbon Dioxide; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen Consumption; Prospective Studies; Pulmonary Gas Exchange; Pulmonary Ventilation; Stroke Volume; Ventricular Function, Left | 1998 |
Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinolysis; Follow-Up Studies; Humans; Isoenzymes; Lipids; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Plasminogen Inactivators; Prognosis; Radionuclide Ventriculography; Recurrence | 1998 |
Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Regional Blood Flow; Streptokinase; Stroke Volume; Survival Rate; Thrombolytic Therapy | 1999 |
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cause of Death; Cerebrovascular Disorders; Confidence Intervals; Diuretics; Female; Follow-Up Studies; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Survival Rate | 1999 |
Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Time Factors; Treatment Outcome | 1999 |
[The CAPITOL study (Captopril Post Infarction Tolerance). A trial of progressive titration of captopril after myocardial infarct with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Aged; Captopril; Drug Tolerance; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 1999 |
Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Pilot Projects; Single-Blind Method | 1999 |
Cardiac protection by long-term treatment with captopril in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Follow-Up Studies; Humans; Myocardial Infarction; Prospective Studies; Ventricular Function, Left | 1998 |
Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome; Ventricular Function, Left | 1999 |
Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIa in early postmyocardial infarction stage.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Captopril; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1999 |
Effects of early captopril therapy after myocardial infarction on the incidence of late potentials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Electrocardiography; Female; Fibrinolytic Agents; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; New Zealand; Predictive Value of Tests; Streptokinase; Survival Analysis | 2000 |
A comparison of intervention with losartan or captopril in acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Female; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Ultrasonography; Ventricular Function, Left | 2000 |
Long-term safety of an early ACE-inhibitor treatment of patients with acute myocardial infarction: results of the 3 year follow-up period on 696 Swiss patients randomized to the ISIS-4 trial. ISIS-Switzerland Study Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Recurrence; Survival Analysis; Switzerland | 2000 |
[Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Meta-Analysis as Topic; Myocardial Infarction; Prospective Studies; Stroke; Survival Rate; Treatment Outcome | 1999 |
First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Female; Humans; Hypotension; Losartan; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 2000 |
[The effect of one-year treatment with captopril on exercise tolerance and myocardial ischemia in patients with myocardial infarction ].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia | 2000 |
Effects of early use of atenolol or captopril on infarct size and ventricular volume: A double-blind comparison in patients with anterior acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Coronary Angiography; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Prospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function | 2001 |
The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Canrenoic Acid; Captopril; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2001 |
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiote
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate | 2001 |
Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Canrenoic Acid; Captopril; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Hemodynamics; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardial Reperfusion; Pilot Projects; Thrombolytic Therapy; Treatment Failure; Ultrasonography | 2001 |
Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2000 |
[Postinfarction remodeling of the left atrium and left ventricle: effects of long-term treatment with beta adrenergic blockers and angiotensin converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Atrial Function, Left; Captopril; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Remodeling | 2001 |
Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Diuretics; Double-Blind Method; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Substance Withdrawal Syndrome; Vasodilator Agents | 2001 |
Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Echocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome; Ventricular Remodeling | 2001 |
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Captopril; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetic Angiopathies; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk; Stroke | 2001 |
Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Female; Follow-Up Studies; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Treatment Outcome | 2001 |
Relationship between age and effect of early and long-term captopril treatment in patients with acute myocardial infarction.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction | 2001 |
Comparison of perindopril versus captopril for treatment of acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Treatment Outcome | 2002 |
[Clinical effect of captopril in diabetic patients with complicated acute myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Treatment Outcome | 1999 |
ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Canrenoic Acid; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardial Reperfusion | 2001 |
Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Circulation; Electrocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Recombinant Proteins; Streptokinase; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |
Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 2002 |
[Chrono-pharmacodynamics of capoten in patients with ischemic heart disease, postinfarction cardiosclerosis with cardiac failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronobiology Phenomena; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sclerosis | 2001 |
Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Dilatation, Pathologic; Heart Ventricles; Humans; Irbesartan; Middle Aged; Myocardial Infarction; Tetrazoles | 2002 |
[Captopril in the treatment of acute myocardial infarction. Hypotension as an important clinical problem].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Female; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Poland; Time Factors; Treatment Outcome | 2002 |
Captopril and glutathione before thrombolysis in acute myocardial infarction: a pilot study.
Topics: Aged; Captopril; Double-Blind Method; Female; Glutathione; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Pilot Projects; Thrombolytic Therapy | 1992 |
Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
Topics: Atrial Natriuretic Factor; Captopril; Cardiac Catheterization; Cardiac Volume; Double-Blind Method; Epinephrine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prospective Studies; Renin-Angiotensin System; Ventricular Function, Left | 1992 |
[Effect of captopril on human myocardial ACE-inhibition: neurohumoral variations during coronary sinus cardioplegia. Cardioprotective effect during aortocoronary bypass].
Topics: Aged; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Disease; Drug Evaluation; Female; Heart Arrest, Induced; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Peptidyl-Dipeptidase A; Placebos | 1992 |
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
Topics: Adult; Captopril; Cardiomegaly; Cardiovascular Diseases; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Stroke Volume; Survival Rate; Ventricular Function, Left | 1992 |
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
Topics: Captopril; Chromium Radioisotopes; Chronic Disease; Creatinine; Edetic Acid; Glomerular Filtration Rate; Heart Failure; Humans; Inulin; Kidney Function Tests; Myocardial Infarction; Renal Circulation; Single-Blind Method; Ventricular Function, Left | 1992 |
Early vasodilator treatment in myocardial infarction: appropriate for the majority or minority?
Topics: Captopril; Double-Blind Method; Echocardiography; Female; Humans; Isosorbide; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardium; Radionuclide Ventriculography; Treatment Outcome; Ventricular Function, Left | 1992 |
The prevention of heart failure--a new agenda.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Follow-Up Studies; Heart Failure; Humans; Myocardial Infarction; Ventricular Function, Left | 1992 |
Effects of converting enzyme inhibition on baroreflex sensitivity in patients with myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Captopril; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Phenylephrine; Pressoreceptors; Reflex; Renin | 1992 |
Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis.
Topics: Captopril; Cardiomegaly; Digoxin; Echocardiography; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Time Factors; Ventricular Function, Left | 1992 |
Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.
Topics: Adult; Aged; Captopril; Cardiac Catheterization; Cardiac Volume; Cardiomegaly; Double-Blind Method; Heart Ventricles; Humans; Middle Aged; Myocardial Contraction; Myocardial Infarction; Observer Variation; Radiography; Time Factors; Ventricular Function, Left | 1992 |
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
Topics: Adult; Aged; Aspirin; Calcium Channel Blockers; Captopril; Cardiomegaly; Cardiovascular Agents; Diltiazem; Drug Utilization; Female; Humans; Male; Middle Aged; Myocardial Infarction; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; United States | 1992 |
[Captopril in acute myocardial infarct: its effect on infarct size and arrhythmias].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Captopril; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis | 1992 |
Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction.
Topics: Aged; Captopril; Chi-Square Distribution; Diastole; Drug Evaluation; Echocardiography; Hemodynamics; Humans; Myocardial Infarction; Systole; Time Factors; Ventricular Function, Left | 1992 |
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Female; Heart Failure; Humans; Male; Myocardial Infarction; Placebos; Stroke Volume; Thrombolytic Therapy; Time Factors; Ventricular Function, Left | 1991 |
Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition.
Topics: Age Factors; Captopril; Cardiac Output, Low; Cause of Death; Coronary Disease; Digitalis Glycosides; Diuretics; Double-Blind Method; Female; Heart Arrest; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Placebos; Regression Analysis; Risk Factors; Systole; Thorax | 1991 |
Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
Topics: Administration, Oral; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Placebos; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Safety; Stroke Volume; Treatment Outcome; Vascular Resistance; Ventricular Function, Left | 1991 |
[Use of captopril in the treatment of circulatory insufficiency in the acute period of myocardial infarction].
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1991 |
Studies of left ventricular dysfunction following myocardial infarction.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Substance Withdrawal Syndrome; Ventricular Function, Left | 1991 |
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.
Topics: Captopril; Cardiomegaly; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide].
Topics: Angiotensin II; Atrial Natriuretic Factor; Captopril; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Renin; Ventricular Function, Left | 1991 |
Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Captopril; Double-Blind Method; Drug Administration Schedule; Echocardiography; Electrocardiography; Exercise Test; Follow-Up Studies; Heart Rate; Humans; Middle Aged; Myocardial Infarction; Recurrence; Stroke Volume; Survival Rate | 1991 |
Efficacy of captopril before thrombolysis in acute myocardial infarction: preliminary findings.
Topics: Arrhythmias, Cardiac; Captopril; Humans; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1990 |
Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Volume; Cardiomegaly; Double-Blind Method; Female; Furosemide; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic | 1990 |
ACE inhibitors after myocardial infarction.
Topics: Captopril; Cardiomegaly; Cardiomyopathy, Dilated; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume | 1989 |
Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Volume; Double-Blind Method; Exercise Test; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Stroke Volume | 1989 |
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Furosemide; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Stroke Volume | 1988 |
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
Topics: Captopril; Cardiomegaly; Clinical Trials as Topic; Dilatation; Exercise Test; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Stroke Volume; Time Factors | 1988 |
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
Topics: Aged; Aldosterone; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prazosin; Random Allocation; Renal Circulation; Renin; Vascular Resistance | 1986 |
252 other study(ies) available for captopril and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril.
Topics: Captopril; Endostatins; Humans; Insulin-Like Growth Factor I; Myocardial Infarction; Obesity | 2020 |
Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Echocardiography; Heart Ventricles; Humans; Male; Mice; Microscopy; Myocardial Infarction; Ventricular Function, Left | 2021 |
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.
Topics: Animals; Captopril; Imidazoles; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2021 |
Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Pressure; Captopril; Cardiomyopathies; Dihydropyridines; Disease Models, Animal; Heart; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley | 2017 |
Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocardial Infarction; Receptors, Adrenergic, alpha-1; Ventricular Remodeling | 2017 |
Neural mechanism of angiotensin-converting enzyme inhibitors in improving heart rate variability and sleep disturbance after myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autonomic Nervous System; Captopril; Electrocardiography; Electroencephalography; Electromyography; Heart Rate; Humans; Male; Myocardial Infarction; Rats; Sleep; Sleep Wake Disorders | 2018 |
Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Adhesion; Cells, Cultured; Cytotoxicity, Immunologic; Enalapril; Human Umbilical Vein Endothelial Cells; Humans; Immunologic Factors; Immunomodulation; Intercellular Adhesion Molecule-1; Lipoxins; Myocardial Infarction; Neutrophils; Receptors, Tumor Necrosis Factor; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2014 |
Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Bradykinin; Captopril; Disease Models, Animal; Male; Morpholines; Myocardial Infarction; Peptidyl-Dipeptidase A; Phenols; Rats; Rats, Wistar; Renin-Angiotensin System | 2014 |
Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sex Factors; Treatment Outcome | 2014 |
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endothelin-1; Glucosides; Heart Ventricles; Hydroxyproline; Hypertrophy; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Phytotherapy; Plant Extracts; Polygonum; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Ventricular Remodeling | 2015 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Topics: Animals; Antihypertensive Agents; Biological Availability; Blotting, Western; Captopril; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Heart; Hydrogen Sulfide; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Ramipril; Random Allocation; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Sulfurtransferases; Swine; Swine, Miniature; Troponin I | 2016 |
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Early Medical Intervention; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Ramipril; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Risk Factors; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Effects of angiotensin converting enzyme inhibition on cardiac innervation and ventricular arrhythmias after myocardial infarction.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Captopril; Electrophysiology; Heart Ventricles; Immunohistochemistry; Myocardial Infarction; Nerve Fibers; Placebos; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2008 |
Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Erythropoietin; Female; Heart Failure; Humans; Losartan; Male; Myocardial Infarction; Prognosis; Retrospective Studies | 2009 |
Inhibition of brain renin-angiotensin system improves diastolic cardiac function following myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Captopril; Diastole; Disease Models, Animal; Echocardiography; Electrocardiography; Injections, Intraventricular; Male; Myocardial Infarction; Rats; Rats, Wistar; Renin-Angiotensin System | 2009 |
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbocyanines; Cardiovascular Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Spironolactone; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Enzyme Activation; Heart Failure; Humans; Isoenzymes; Losartan; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2009 |
Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction.
Topics: Acute Disease; Animals; Blood Pressure; Captopril; Coronary Circulation; Echocardiography; Extracellular Matrix; Factor VIII; Fibroblasts; Hemodynamics; Myocardial Infarction; Prosthesis Implantation; Rats; Regional Blood Flow; Systole; Ventricular Function, Left | 2009 |
Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Biomarkers; Captopril; Child; Coronary Angiography; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography; Electrocardiography; Humans; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 2009 |
Cardioprotective effect of ornitho-kinin in an anesthetized, open-chest chicken model of acute coronary occlusion.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Cardiotonic Agents; Chickens; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Kinins; Myocardial Infarction; Preoperative Care; Vascular Resistance; Vasodilator Agents | 2009 |
Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat.
Topics: Animals; Captopril; Cardiotonic Agents; Female; Garlic; Herb-Drug Interactions; Isoproterenol; Myocardial Infarction; Myocardium; Plant Extracts; Rats; Rats, Wistar | 2010 |
Effects of Tongguan Capsule on post-myocardial infarction ventricular remodeling and cardiac function in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Capsules; Captopril; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Echocardiography, Doppler; Heart; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2010 |
[Effects of Chinese herbal medicines Shengmai injection and Xuesaitong injection on ventricular fibrillation threshold and connexin 43 expression in rats with myocardial infarction].
Topics: Animals; Captopril; Connexin 43; Drug Combinations; Drugs, Chinese Herbal; Injections; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2011 |
Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Captopril; Heart Rate; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Pyridines; Rats; Rats, Wistar; Risk Factors | 2011 |
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly; Collagen; Coronary Vessels; Endothelin-1; Ethanol; Gene Expression Regulation; Hemodynamics; Hydroxyproline; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Scrophularia; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2012 |
[Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction; Time Factors | 2012 |
The OPTIMAAL trial: losartan or captopril after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Losartan; Myocardial Infarction; Time Factors | 2002 |
The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Losartan; Myocardial Infarction | 2002 |
The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Losartan; Myocardial Infarction | 2002 |
The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Losartan; Myocardial Infarction | 2002 |
The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Losartan; Myocardial Infarction | 2002 |
Effect of angiotensin converting enzyme inhibition on myocardial phosphoinositide metabolism visualised with 1-[1-11C]-butyryl-2-palmitoyl-rac-glycerol in myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Autoradiography; Captopril; Carbon Radioisotopes; Glycerides; Heart Ventricles; Humans; Male; Myocardial Infarction; Myocardium; Phosphatidylinositols; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Tissue Distribution; Ventricular Remodeling | 2002 |
[Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Female; Humans; Length of Stay; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Captopril; Disease Models, Animal; Endothelium, Vascular; Female; Hemodynamics; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Vasodilation; Ventricular Fibrillation | 2003 |
Influence of angiotensin converting enzyme inhibitors on stable myocardial ischemia in menopausal cardiac patients.
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Electrocardiography; Exercise Test; Female; Humans; Middle Aged; Myocardial Infarction; Postmenopause; Prospective Studies | 2003 |
Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2003 |
What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Heart Failure; Humans; Losartan; Myocardial Infarction; Randomized Controlled Trials as Topic | 2003 |
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiotonic Agents; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Failure; Ventricular Remodeling | 2003 |
[Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Drug Prescriptions; Enalapril; Evidence-Based Medicine; Female; Guideline Adherence; Humans; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Myocardial Infarction; Nitrates; Outpatients; Platelet Aggregation Inhibitors; Practice Guidelines as Topic | 2003 |
The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
Topics: Aged; Angiotensin Receptor Antagonists; Captopril; Double-Blind Method; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptide Fragments; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Survival Rate; Tetrazoles; Valine; Valsartan | 2003 |
Valsartan an alternative to ACE inhibitor in high-risk MI.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Capillaries; Captopril; Coronary Circulation; Glucocorticoids; Heart Rate; Hypertrophy, Left Ventricular; Imidazoles; Male; Methylprednisolone; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Wistar; Sympatholytics | 2004 |
[When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[New options against undertreatment].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Heart Failure; Hospitalization; Humans; Losartan; Myocardial Infarction; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Atrial Fibrillation; Captopril; Chest Pain; Colorectal Neoplasms; Coronary Angiography; Digoxin; Disease Management; Echocardiography; Electrocardiography; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Myocardial Infarction; Nitrates; Verapamil | 2003 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Ethics, Clinical; Heart Failure; Humans; Myocardial Infarction; Placebos; Research Design; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Kidney Diseases; Myocardial Infarction; Tetrazoles; Valine; Valsartan | 2004 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypotension; Myocardial Infarction; Tetrazoles; Valine; Valsartan | 2004 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Catechol O-Methyltransferase; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies | 2004 |
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Enalapril; Evaluation Studies as Topic; Female; Hospitalization; Humans; Lisinopril; Male; Myocardial Infarction; Patient Discharge; Pharmacoepidemiology; Ramipril; Randomized Controlled Trials as Topic | 2004 |
Valsartan in acute myocardial infarction trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Male; Myocardial Infarction; Tetrazoles; Valine; Ventricular Dysfunction, Left | 2004 |
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Kidney; Male; Myocardial Infarction; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Ventricular Function, Left | 2004 |
Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Organ Size; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Thiazepines | 2004 |
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
[Myocardial protective effects of pretreatment with captopril on ischemia-reperfusion myocardium in rabbits].
Topics: Animals; Captopril; Endothelins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Rabbits; Random Allocation | 2005 |
Connective tissue growth factor and cardiac fibrosis after myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen Type I; Connective Tissue Growth Factor; Fibrosis; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2005 |
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Captopril; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Heart Failure; Humans; Hypokalemia; Hypotension; Losartan; Meta-Analysis as Topic; Myocardial Infarction; Renal Insufficiency; Tetrazoles; Valine | 2005 |
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Drug Therapy, Combination; Heart Ventricles; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Lisinopril; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Ventricular Function | 2005 |
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemokine CCL2; Creatinine; Female; Heart Failure; Humans; Immunoenzyme Techniques; Interleukin-6; Losartan; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Assessment; Solubility | 2005 |
Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Hemodynamics; Kidney; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger | 2006 |
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cardiovascular Diseases; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Valine; Valsartan | 2006 |
[Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Long-Term Care; Myocardial Infarction; Secondary Prevention; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction.
Topics: Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Growth Hormone; Humans; Myocardial Infarction; Neovascularization, Pathologic; Swine; Ventricular Remodeling | 2006 |
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Captopril; Drug Therapy, Combination; Female; Humans; Internationality; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2006 |
Left bundle branch block is not good for your heart.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Heart Failure; Humans; Myocardial Infarction; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Electrocardiography; Enalapril; Female; Fosinopril; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Research Design; Stroke Volume; Time Factors; Treatment Outcome | 2007 |
[ACE inhibitors after myocardial infarction: close-up on zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic | 2007 |
Role of renin-angiotensin system in development of heart failure induced by myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Echocardiography; Electrocardiography; Heart Failure; Myocardial Infarction; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 2007 |
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.
Topics: Animals; Captopril; Cardiotonic Agents; Diiodothyronines; Drug Therapy, Combination; Gene Expression Regulation; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Heart Failure; Heart Rate; Male; Mitochondrial Proteins; Mitochondrial Proton-Translocating ATPases; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transcriptional Activation; Ventricular Function, Left | 2007 |
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Controlled Clinical Trials as Topic; History, 20th Century; History, 21st Century; Humans; Hypertension; Myocardial Infarction | 2007 |
Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Heart Failure; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Portal Vein; Rats; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2008 |
From black and white to shades of gray: race and renin-angiotensin system blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Captopril; Heart Failure; Humans; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Black or African American; Captopril; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Systole; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
[Cardiology 1983--results, problems, developments].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon; Arrhythmias, Cardiac; Bundle of His; Captopril; Cardiac Glycosides; Coronary Disease; Coronary Vessels; Dihydroergotamine; Echocardiography; Electrocoagulation; Fibrinolysis; Heart Failure; Heparin; Humans; Myocardial Infarction; Pacemaker, Artificial; Thromboembolism | 1983 |
Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Dogs; Female; Hematocrit; Hemodynamics; Male; Myocardial Infarction; Proline; Renin | 1982 |
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Topics: Aged; Aldosterone; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Proline; Renin | 1983 |
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Prazosin; Regional Blood Flow; Vasoconstriction; Vasodilator Agents | 1983 |
Beneficial effect of captopril in a patient with congestive heart failure and ischemic interventricular septal rupture.
Topics: Captopril; Drug Therapy, Combination; Heart Failure; Heart Rupture; Heart Septum; Humans; Male; Middle Aged; Myocardial Infarction; Proline; Vasodilator Agents | 1983 |
[Captopril (Capoten) in the treatment of heart insufficiency].
Topics: Captopril; Heart Failure; Humans; Kinetics; Myocardial Infarction; Proline | 1984 |
Captopril in refractory heart failure: clinical and hemodynamic observations.
Topics: Adult; Aged; Captopril; Female; Follow-Up Studies; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Proline | 1983 |
[The effect of captopril in the patient with acute myocardial infarction].
Topics: Aged; Captopril; Drug Evaluation; Female; Humans; Male; Middle Aged; Myocardial Infarction; Proline | 1984 |
[Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
Topics: Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Proline; Renin-Angiotensin System | 1983 |
Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction.
Topics: Aged; Captopril; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Proline | 1982 |
Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction.
Topics: Acute Disease; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Proline; Renin | 1981 |
Captopril in severe treatment-resistant hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Myocardial Infarction; Proline; Propranolol; Renin | 1980 |
Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia.
Topics: Animals; Captopril; Dogs; Fluorocarbons; Flurbiprofen; Myocardial Infarction; Myocardium; Necrosis; Verapamil | 1981 |
Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Captopril; Heart; Heart Rate; Imidazoles; Losartan; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
Topics: Animals; Captopril; Catecholamines; Coronary Circulation; Deoxyepinephrine; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Heart Ventricles; Male; Myocardial Infarction; Rats; Rats, Wistar | 1994 |
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Deoxyepinephrine; Disease Models, Animal; Dopamine Agonists; Drug Therapy, Combination; Heart Rate; Hemodynamics; Isoproterenol; Male; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Pressure | 1995 |
ISIS-4. GISSI-3 Investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Humans; Lisinopril; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Rate | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
ISIS-4.
Topics: Angina, Unstable; Captopril; Humans; Hypotension; Magnesium Sulfate; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Rate; Thrombolytic Therapy | 1995 |
Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.
Topics: Animals; Captopril; Collagen; Dogs; Echocardiography; Electrocardiography; Enalapril; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Systole; Time Factors; Ventricular Function, Left | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Humans; Myocardial Infarction | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Myocardial Infarction | 1995 |
[Utilization of angiotensin-converting enzyme inhibitors in anterior infarction without congestive semiology].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
Vasodilators after myocardial infarction-ISIS IV.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Magnesium; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Vasodilator Agents | 1994 |
[A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure].
Topics: Adult; Aged; Animals; Captopril; Coronary Circulation; Drug Therapy, Combination; Female; Heart Failure; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Rats; Rats, Sprague-Dawley | 1994 |
Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen.
Topics: Animals; Captopril; Collagen; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Magnesium and myocardial infarction.
Topics: Aspirin; Captopril; Drug Therapy, Combination; Heparin; Humans; Magnesium; Myocardial Infarction; Streptokinase | 1994 |
Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage.
Topics: Animals; Captopril; Dogs; Hemodynamics; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Metoprolol; Myocardial Infarction; Random Allocation; Stroke Volume; Ventricular Function | 1994 |
ACE inhibition in acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Topics: Alanine; Amino Acid Sequence; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Captopril; Cardiomegaly; Dioxoles; Disease Models, Animal; Heart Failure; Hormones; Male; Molecular Sequence Data; Myocardial Infarction; Myocardium; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin | 1994 |
An ACE inhibitor after a myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Myocardial Infarction; Ventricular Function, Left | 1994 |
Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
Topics: Animals; Blood Pressure; Captopril; Creatine Kinase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
[Magnesium in myocardial infarct].
Topics: Captopril; Humans; Infusions, Intravenous; Injections, Intravenous; Magnesium; Magnesium Sulfate; Myocardial Infarction; Thrombolytic Therapy | 1994 |
Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?
Topics: Action Potentials; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Heart; Hypertension; Indoles; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Rats, Wistar | 1994 |
Effects of captopril therapy after late reperfusion on left ventricular remodeling after experimental myocardial infarction.
Topics: Animals; Captopril; Cardiac Volume; Female; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Myocardial Reperfusion; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Pressure | 1994 |
[After myocardial infarction, captopril improves the prognosis].
Topics: Animals; Captopril; Humans; Myocardial Infarction; Prognosis | 1993 |
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Propranolol; Rats; Rats, Wistar; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 1994 |
Do angiotensin converting enzyme inhibitors limit myocardial infarct size?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Rabbits; Ramipril; Renin | 1993 |
[Captopril in the treatment of congestive heart failure in acute myocardial infarct].
Topics: Aged; Captopril; Heart Failure; Humans; Middle Aged; Myocardial Infarction | 1993 |
Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure.
Topics: Animals; Captopril; Diiodothyronines; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 1993 |
An inappropriate article.
Topics: Captopril; Humans; Myocardial Infarction; Renal Artery; Vasoconstriction | 1993 |
More on the survival and ventricular enlargement trial.
Topics: Captopril; Electrocardiography; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Recurrence; Ventricular Function, Left | 1993 |
Myocardial infarction and heart failure. The common ground.
Topics: Captopril; Cardiac Output, Low; Enalapril; Humans; Myocardial Infarction | 1993 |
ACE inhibitors after myocardial infarction.
Topics: Captopril; Death, Sudden; Humans; Myocardial Infarction | 1993 |
ACE inhibitors after myocardial infarction.
Topics: Captopril; Female; Humans; Male; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
[Treatment with ACE inhibitors after acute myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction; Ventricular Function, Left | 1993 |
Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.
Topics: Angiotensin II; Animals; Benzamidines; Bradykinin; Captopril; Dogs; Guanidines; Hemodynamics; Male; Myocardial Infarction; Oligopeptides; Serine Proteinase Inhibitors | 1993 |
Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart; Hemodynamics; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Wistar | 1995 |
Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
Topics: Adenine Nucleotides; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Energy Metabolism; Heart Failure; Hemodynamics; Indoles; Lactates; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Phosphocreatine; Rats; Rats, Wistar | 1995 |
Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiac Output; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Growth Hormone; Heart Failure; Heart Rate; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1995 |
Survival after myocardial infarction in rats: captopril versus losartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Confounding Factors, Epidemiologic; Disease Models, Animal; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Analysis; Tetrazoles; Time Factors | 1996 |
Economic aspects of treatment with captopril after MI.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Cost-Benefit Analysis; Drug Costs; Humans; Myocardial Infarction; Preventive Medicine | 1996 |
Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiac Output, Low; Echocardiography, Doppler; Electrocardiography; Male; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 1996 |
Relative contribution of angiotensin II, bradykinin, and prostaglandins to the renal effects of converting enzyme inhibition in rats after chronic myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cyclooxygenase Inhibitors; Hemodynamics; Imidazoles; Indomethacin; Kidney; Kidney Function Tests; Losartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anxiety; Arousal; Captopril; Escape Reaction; Fear; Male; Maze Learning; Myocardial Infarction; Rats; Rats, Wistar; Social Environment | 1996 |
[Economical treatment of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Heart Failure; Humans; Myocardial Infarction | 1996 |
Sensitivity to ischemia of chronically infarcted rat hearts; effects of long-term captopril treatment.
Topics: Adenosine; Animals; Blood Flow Velocity; Captopril; Ischemia; Male; Myocardial Infarction; Perfusion; Rats; Rats, Wistar; Sensitivity and Specificity | 1996 |
'Quality of life' after therapy in rats with myocardial infarction: dissociation between hemodynamic and behavioral improvement.
Topics: Animals; Behavior, Animal; Captopril; Dobutamine; Exploratory Behavior; Grooming; Hemodynamics; Male; Motor Activity; Myocardial Infarction; Quality of Life; Rats; Rats, Wistar | 1996 |
Responses to acute myocardial stress and prior drug therapy on plasma levels of antioxidants and oxidants and the proposed role of interventions on molecular adaptations.
Topics: Anti-Arrhythmia Agents; Antioxidants; Captopril; Humans; Myocardial Infarction; Oxidants; Propranolol | 1996 |
Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Ischemic Preconditioning, Myocardial; Kinins; Myocardial Infarction; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin | 1996 |
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Ventricular Dysfunction, Left | 1997 |
Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Humans; Myocardial Infarction; Neurotransmitter Agents; Survival Rate; Ventricular Dysfunction, Left | 1997 |
Economic aspects of captopril treatment.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis | 1997 |
Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats.
Topics: Animals; Captopril; Catalase; Glutathione Peroxidase; Heart; Heart Failure; Hemodynamics; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Prazosin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vasodilator Agents; Ventricular Function, Left | 1997 |
Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
Topics: Animals; Captopril; Cardiotonic Agents; Deoxyepinephrine; Endothelium, Vascular; Hemodynamics; Male; Myocardial Infarction; Norepinephrine; Rats; Rats, Wistar; Vasodilator Agents | 1997 |
Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dogs; Enalapril; Heart Ventricles; Hydroxyproline; Hypertrophy, Left Ventricular; Myocardial Infarction; Ultrasonography | 1997 |
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Dilatation, Pathologic; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Myocardium; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Ventricular Function, Left; Ventricular Pressure | 1997 |
Effects of captopril on interstitial collagen in the myocardium after infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Collagen; Disease Models, Animal; Fibrosis; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 1997 |
Changes in myocardial density during postinfarction healing: effect on estimation of in vivo left ventricular mass by echocardiographic imaging.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Female; Formaldehyde; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organ Size; Tissue Fixation; Ultrasonography | 1997 |
Effect of delayed intervention with ACE-inhibitor therapy on myocyte hypertrophy and growth of the cardiac interstitium in the rat model of myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Collagen; Disease Models, Animal; Drug Administration Schedule; Endothelium, Vascular; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Renin | 1997 |
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
[Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Heart; Heart Ventricles; Hemodynamics; Hydroxyproline; Losartan; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Proteins; Rats; Rats, Inbred Strains; Rats, Wistar; Vasoconstrictor Agents | 1997 |
[Acute myocardial infarct in Switzerland: results from the PIMICS Heart Infarct Register. PIMICS Project (Prospective Ischemia Myocardial Infarction Captopril Survey)].
Topics: Adult; Aged; Captopril; Cross-Sectional Studies; Female; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Patient Admission; Registries; Switzerland; Treatment Outcome | 1998 |
Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Health Care Costs; Humans; Italy; Myocardial Infarction; Sensitivity and Specificity | 1998 |
Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Ramipril | 1998 |
The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain; Captopril; Evaluation Studies as Topic; Heart Failure; Hemodynamics; Losartan; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |
[The protective effect of captopril on the ischemic myocardium in dogs through coronary sinus retroperfusion].
Topics: Animals; Captopril; Coronary Vessels; Dogs; Endothelins; Female; Free Radical Scavengers; Injections, Intravenous; Male; Malondialdehyde; Myocardial Infarction | 1997 |
Reduced periinfarction mortality as a result of long-term therapy with captopril but not hydralazine or propranolol in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Collagen; Electric Stimulation; Heart Rate; Hydralazine; Hypertension; Image Processing, Computer-Assisted; Male; Myocardial Infarction; Propranolol; Rats; Rats, Inbred SHR; Survival Analysis | 1998 |
Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; DNA; Drug Implants; Endothelium, Vascular; Indoles; Male; Myocardial Infarction; Perfusion; Rats; Rats, Wistar; Time Factors | 1998 |
Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Humans; Losartan; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Survival Analysis; Treatment Outcome | 1999 |
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ventricular Function, Left | 1999 |
Mortality in patients treated with captopril for left ventricular dysfunction following myocardial infarction.
Topics: Actuarial Analysis; Aged; Captopril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1992 |
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Coronary Vessels; Lactates; Ligation; Male; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Purines; Rats; Rats, Wistar | 1999 |
Effect of losartan and captopril on expression of cardiac angiotensin II AT1 receptor mRNA in rats following myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Gene Expression Regulation; Losartan; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger | 1997 |
The role of endothelin-1 in the aorta of post-infarct left ventricular dysfunction rats treated with captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Endothelin-1; Hemodynamics; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 1998 |
Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.
Topics: Animals; Blood Pressure; Calcium; Calcium-Transporting ATPases; Captopril; Gene Expression Regulation; Heart Failure; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 18S; RNA, Ribosomal, 28S; Sarcoplasmic Reticulum; Ventricular Function, Left | 1999 |
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors | 1999 |
[The effect of a combination ACE inhibitor and beta-blockers in acute myocardial infarct].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Combinations; Humans; Metoprolol; Myocardial Infarction | 1999 |
Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Captopril; Coronary Vessels; Endocardium; Endothelium, Vascular; Heart; Immunohistochemistry; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; RNA, Messenger; Serotonin | 1999 |
Effects of stimulation frequency on calcium transients in noninfarcted myocardium: modulation by chronic captopril treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Signaling; Captopril; Disease Models, Animal; Electric Stimulation; Heart Failure; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Fluid; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley | 1999 |
Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Echocardiography; Female; Hemodynamics; Losartan; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function, Left | 1999 |
Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Body Weight; Captopril; Creatine; Creatine Kinase; Energy Metabolism; Isoenzymes; Male; Myocardial Infarction; Myocardium; Organ Size; Phosphocreatine; Rats; Rats, Wistar; Reference Values; Ventricular Function, Left | 1999 |
Regional and temporal profiles of phorbol 12,13-dibutyrate binding after myocardial infarction in rats: effects of captopril treatment.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Autoradiography; Captopril; Carcinogens; Male; Myocardial Infarction; Organ Size; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Time Factors; Ventricular Remodeling | 2000 |
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Captopril; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Treatment Outcome; Ventricular Fibrillation | 2000 |
MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.
Topics: Adenine Nucleotides; Animals; Calcium; Captopril; Cardiovascular Agents; Energy Metabolism; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart; Heart Failure; In Vitro Techniques; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2000 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Female; Heart; Heart Failure; Humans; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Randomized Controlled Trials as Topic; Spironolactone; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
National guidelines, clinical trials, and quality of evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Evidence-Based Medicine; Humans; Hypertension; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Treatment Outcome; United Kingdom; United States | 2000 |
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II.
Topics: Angiotensin II; Animals; Captopril; Models, Cardiovascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine | 2000 |
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Myocardial Infarction; Odds Ratio; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Sample Size; Tetrazoles; Valine; Valsartan | 2000 |
Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiovascular System; Disease Models, Animal; Female; Heart Failure; Hormones; Kidney; Methionine; Myocardial Infarction; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Water | 2000 |
Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Gene Expression; Heart; Heart Function Tests; Heart Rate; Male; Myocardial Infarction; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2001 |
[ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Confidence Intervals; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Practice Guidelines as Topic; Ramipril; Registries; Sampling Studies; Surveys and Questionnaires; Time Factors; Ventricular Dysfunction, Left | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infarcted rat hearts: effects of captopril treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Body Weight; Captopril; Diacylglycerol Kinase; Disease Models, Animal; Gene Expression; Granulocytes; Heart Ventricles; Immunohistochemistry; In Situ Hybridization; Isoenzymes; Macrophages; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling | 2001 |
Comparative effects of losartan and captopril on ventricular remodeling and function after myocardial infarction in the rat.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Function Tests; Losartan; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ultrasonography; Ventricular Remodeling | 1998 |
Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure.
Topics: Age Factors; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Captopril; Cardiomegaly; Coronary Disease; Disease Models, Animal; Heart Failure; Heart Septum; Ligation; Male; Mice; Mice, Inbred C57BL; Multivariate Analysis; Myocardial Infarction; Survival Rate | 2002 |
Aldosterone and myocardial infarction--are aldosterone antagonists needed to prevent remodelling or does ACE inhibition suffice?
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Canrenoic Acid; Captopril; Cardiomegaly; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Peptidyl-Dipeptidase A | 2001 |
Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Coronary Circulation; Cytokines; Heart; Hemodynamics; Interleukin-10; Male; Myocardial Infarction; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazepines; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |
Study on early intervention with ACE inhibitor in myocardical infarction and short term outcome.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Function, Left | 2001 |
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Male; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Rats; Rats, Wistar; Thiazepines; Treatment Outcome; Ventricular Remodeling | 2002 |
Reduced left ventricular diastolic asynchrony after captopril in single vessel coronary artery disease.
Topics: Aged; Captopril; Coronary Disease; Diastole; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 1992 |
[The effect of captopril on plasma endothelin and calcitonin gene related peptide (CGRP) in patients with acute myocardial infarction].
Topics: Calcitonin Gene-Related Peptide; Captopril; Endothelins; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1992 |
Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure.
Topics: Animals; Calcium; Captopril; Heart; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1992 |
Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cardiac Output, Low; Disease Models, Animal; Down-Regulation; Guanylate Cyclase; Hemodynamics; Kidney; Kidney Glomerulus; Kinetics; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Renal Circulation; Renin-Angiotensin System | 1992 |
Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiac Output; Enalaprilat; Heart Failure; Hemodynamics; Hypertension; Injections, Intravenous; Male; Myocardial Infarction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Vascular Resistance | 1992 |
Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Coronary Disease; Dogs; Myocardial Infarction; Myocardial Reperfusion; Perfusion; Random Allocation | 1992 |
Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Down-Regulation; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Rats; Rats, Inbred Strains | 1992 |
Mechanical performance of spared myocytes after myocardial infarction in rats: effects of captopril treatment.
Topics: Animals; Captopril; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley | 1992 |
Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats.
Topics: Animals; Captopril; Cell Cycle; Cell Nucleus; Cell Separation; DNA; Flow Cytometry; Heart; Heart Ventricles; Hemodynamics; Hyperplasia; Male; Mitosis; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Time Factors | 1992 |
Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.
Topics: Angiotensin II; Animals; Benzamidines; Blood Pressure; Bradykinin; Captopril; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Guanidines; Heart; Hemodynamics; Kallikreins; Male; Myocardial Infarction; Myocardium; Vascular Resistance | 1992 |
Baroreflex control of heart rate in rats with heart failure after myocardial infarction: effects of captopril.
Topics: Animals; Blood Pressure; Captopril; Heart Failure; Heart Rate; Male; Myocardial Infarction; Norepinephrine; Pressoreceptors; Rats; Rats, Sprague-Dawley; Reflex | 1992 |
Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction.
Topics: Animals; Captopril; Cicatrix; Coronary Angiography; Dogs; Echocardiography; Female; Heart; Heart Ventricles; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Time Factors; Ventricular Function, Left | 1992 |
Geometric adaptation to afterload reduction: understanding left ventricular remodeling after myocardial infarction.
Topics: Animals; Captopril; Dogs; Myocardial Infarction; Myocardium; Ventricular Function, Left | 1992 |
Effects of captopril on infarct expansion.
Topics: Captopril; Humans; Informed Consent; Myocardial Infarction; Research Design | 1992 |
Effect of left ventricular unloading with captopril on remodelling and function during healing of anterior transmural myocardial infarction in the dog.
Topics: Animals; Captopril; Collagen; Disease Models, Animal; Dogs; Echocardiography; Female; Hemodynamics; Male; Myocardial Infarction; Random Allocation; Ventricular Function, Left | 1992 |
Captopril following acute myocardial infarction.
Topics: Captopril; Heart Failure; Humans; Myocardial Infarction | 1992 |
Effects of captopril on regional segment motion during acute coronary occlusion.
Topics: Animals; Captopril; Coronary Circulation; Dogs; Electrocardiography; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Ventricular Function, Left | 1992 |
[Heart diseases in light of SAVE-Study. Captopril improves prognosis and symptoms of left ventricular dysfunction after myocardial infarction. 41st scientific annual meeting of the American College of Cardiology. Dallas, Texas, 12-16 April 1992].
Topics: Captopril; Humans; Myocardial Infarction; Ventricular Function, Left | 1992 |
[The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 1991 |
Early intervention with angiotensin-converting enzyme inhibitors during thrombolytic therapy in acute myocardial infarction: rationale and design of captopril and thrombolysis study. CATS investigators group.
Topics: Captopril; Clinical Protocols; Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Myocardial Infarction; Pilot Projects; Research Design; Streptokinase; Thrombolytic Therapy | 1991 |
Effects of captopril on contractility after myocardial infarction: experimental observations.
Topics: Animals; Blood Pressure; Blood Volume; Captopril; Cardiac Output, Low; Collagen; Hydroxyproline; Isometric Contraction; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Size; Papillary Muscles; Rats; Rats, Inbred Strains; Vascular Resistance | 1991 |
Fourth International Study of Infarct Survival: protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium. ISIS-4 collaborative group.
Topics: Administration, Oral; Captopril; Clinical Trials as Topic; Delayed-Action Preparations; Fibrinolytic Agents; Humans; Injections, Intravenous; Isosorbide Dinitrate; Magnesium; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Thrombolytic Therapy | 1991 |
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril.
Topics: Animals; Captopril; Coronary Vessels; DNA; Hydralazine; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Angiotensin I converting enzyme inhibitors and cardiac remodeling.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Collagen; DNA; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Inbred Strains | 1991 |
The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Heart Ventricles; Male; Myocardial Infarction; Organ Size; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition.
Topics: Analysis of Variance; Animals; Blood Pressure; Captopril; Cardiac Volume; Cardiomegaly; Cicatrix; Female; Longitudinal Studies; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Stroke Volume; Survival Rate; Ventricular Function, Left | 1991 |
Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.
Topics: Adult; Aged; Captopril; Cardiomegaly; Clinical Protocols; Clinical Trials as Topic; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Research Design; Stroke Volume; Ventricular Function, Left | 1991 |
Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.
Topics: Administration, Oral; Angiotensin II; Animals; Body Weight; Captopril; Cardiac Output, Low; Compliance; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Tetrazoles; Ventricular Function, Left | 1991 |
[Hemodynamic effects of captopril in acute infarct of the anterior myocardium].
Topics: Administration, Sublingual; Aged; Captopril; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction | 1991 |
Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Animals; Captopril; Coronary Circulation; Creatine Kinase; Female; Free Radical Scavengers; Lipid Peroxidation; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Swine | 1991 |
Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Inbred Strains | 1991 |
Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction.
Topics: Animals; Captopril; Drug Administration Schedule; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Inbred Strains | 1991 |
The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Creatine Kinase; Electric Stimulation; Heart; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Purines; Renin; Swine; Tachycardia; Time Factors; Ventricular Function | 1990 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
Early and late effects of captopril treatment after large myocardial infarction in rats.
Topics: Animals; Captopril; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction.
Topics: Animals; Body Weight; Captopril; Coenzymes; Drug Synergism; Energy Metabolism; Female; Heart Failure; Hemodynamics; Myocardial Infarction; Organ Size; Rats; Survival Rate; Ubiquinone | 1990 |
Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
Topics: Angiotensin II; Blood Pressure; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure; Renin | 1987 |
Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.
Topics: Angiotensin II; Animals; Captopril; Coronary Disease; Electric Stimulation; Electrophysiology; Hemodynamics; Male; Myocardial Infarction; Swine; Tachycardia | 1989 |
Effects of captopril and NaCl loading on plasma atrial natriuretic peptide (ANP) in rat with chronic heart failure.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Chronic Disease; Coronary Vessels; Heart Diseases; Ligation; Male; Myocardial Infarction; Natriuresis; Rats; Rats, Inbred Strains; Renin; Sodium Chloride | 1989 |
Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine.
Topics: Animals; Blood Volume; Captopril; Chronic Disease; Heart; Heart Ventricles; Hydralazine; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Stroke Volume; Vasodilator Agents; Veins | 1989 |
[Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
Topics: Amiodarone; Arrhythmias, Cardiac; Captopril; Death, Sudden; Humans; Metoprolol; Multicenter Studies as Topic; Myocardial Infarction; Spain | 1989 |
[The hemodynamic effect of Capoten in patients with myocardial infarct complicated by heart failure].
Topics: Aged; Captopril; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 1989 |
Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.
Topics: Angiotensin I; Animals; Captopril; Coronary Circulation; Coronary Disease; Enalapril; Epoprostenol; Female; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Rats | 1987 |
Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Indoles; Male; Myocardial Infarction; Perindopril; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1987 |
[Therapeutic recommendation in cardiac insufficiency. Initial treatment--after infarct--in kidney disease].
Topics: Captopril; Heart Diseases; Humans; Kidney Diseases; Myocardial Infarction | 1987 |
Effect of captopril on ventricular dilatation after anterior myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Cardiac Volume; Heart Ventricles; Humans; Myocardial Infarction; Rats | 1988 |
Functional infarct expansion, left ventricular dilation and isovolumic relaxation time after coronary occlusion: a two-dimensional echocardiographic study.
Topics: Animals; Captopril; Cardiomegaly; Coronary Circulation; Dogs; Echocardiography; Female; Heart Ventricles; Hemodynamics; Indoles; Male; Myocardial Contraction; Myocardial Infarction; Organometallic Compounds; Random Allocation; Time Factors | 1988 |
The use of angiotensin converting enzyme inhibitors in elderly patients with hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Interactions; Enalapril; Hemodynamics; Humans; Hypertension; Myocardial Infarction | 1987 |
Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure.
Topics: Animals; Blood Pressure; Captopril; Female; Heart Failure; Hemodynamics; Hypertension; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1988 |
Neuroendocrine changes in acute myocardial infarction.
Topics: Aldosterone; Arginine Vasopressin; Captopril; Catecholamines; Humans; Myocardial Infarction; Neurosecretory Systems; Renin-Angiotensin System; Sympathetic Nervous System; Thyroid Hormones | 1988 |
[Effect of peripheral vasodilators on the local contractile function of the myocardium in patients with post-infarction cardiosclerosis].
Topics: Aged; Captopril; Endomyocardial Fibrosis; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin | 1988 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
Effects of intravenous captopril on inducible sustained ventricular tachycardia one week after experimental infarction in the anaesthetized pig.
Topics: Animals; Captopril; Creatine Kinase; Male; Myocardial Infarction; Swine; Tachycardia | 1986 |
Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Topics: Aged; Aged, 80 and over; Blood Pressure; Captopril; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance | 1986 |
Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.
Topics: Animals; Blood Pressure; Captopril; Heart Failure; Longevity; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Stroke Volume | 1987 |
Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
Topics: Animals; Captopril; Cardiac Output; Exercise Test; Hemodynamics; Male; Microspheres; Muscles; Myocardial Infarction; Oxygen Consumption; Rats; Rats, Inbred Strains; Regional Blood Flow | 1987 |
[Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].
Topics: Animals; Benzazepines; Captopril; Coronary Circulation; Digestive System; Diltiazem; Heart Failure; Hemodynamics; Male; Muscles; Myocardial Infarction; Physical Exertion; Proline; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin | 1985 |
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
Topics: Animals; Captopril; Cardiac Output; Cardiac Volume; Female; Heart Ventricles; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Proline; Rats; Rats, Inbred Strains | 1985 |
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
Topics: Animals; Captopril; Female; Heart Failure; Heart Ventricles; Myocardial Infarction; Proline; Rats; Rats, Inbred Strains; Time Factors | 1985 |